<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">98063</article-id><article-id pub-id-type="doi">10.7554/eLife.98063</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.98063.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Dock-and-lock binding of SxIP ligands is required for stable and selective EB1 interactions</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Almeida</surname><given-names>Teresa</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9308-8678</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Hargreaves</surname><given-names>Eleanor</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9287-8480</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Zech</surname><given-names>Tobias</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Barsukov</surname><given-names>Igor</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4406-9803</contrib-id><email>igb2@liverpool.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04xs57h96</institution-id><institution>Department of Biochemistry, Cell Signalling and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool</institution></institution-wrap><addr-line><named-content content-type="city">Liverpool</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04xs57h96</institution-id><institution>Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool</institution></institution-wrap><addr-line><named-content content-type="city">Liverpool</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Roche</surname><given-names>Julien</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04rswrd78</institution-id><institution>Iowa State University</institution></institution-wrap><addr-line><named-content content-type="city">Ames</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University Frankfurt</institution></institution-wrap><addr-line><named-content content-type="city">Frankfurt am Main</named-content></addr-line><country>Germany</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>10</day><month>12</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP98063</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-04-05"><day>05</day><month>04</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-02-29"><day>29</day><month>02</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.02.27.581919"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-07-05"><day>05</day><month>07</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.98063.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-08-28"><day>28</day><month>08</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.98063.2"/></event></pub-history><permissions><copyright-statement>© 2024, Almeida, Hargreaves et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Almeida, Hargreaves et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-98063-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-98063-figures-v1.pdf"/><abstract><p>End binding protein 1 (EB1) is a key component of the signalling networks at microtubule plus ends. It contains an N-terminal microtubule-binding CH domain and a C-terminal EBH domain interacting with SxIP-containing sequences of other microtubule plus end tracking proteins (+TIPs). Using a series of SxIP-containing peptides derived from the microtubule-actin cross-linking factor (MACF), we demonstrate that the SxIP motif itself binds to EBH with low affinity, and that the full interaction requires contribution of residues following the SxIP motif. Based on the solution structure and dynamics of the EBH/MACF complex, we propose a two-step ‘dock-and-lock’ model for the EBH interaction with targets, where the SxIP motif initially binds to a partially formed EBH pocket. This subsequently induces folding of the unstructured C-terminus and transition to a stable complex. We dissect contributions into the binding and design MACF mutations of the post-SxIP region that enhance the affinity by two orders of magnitude, leading to a nanomolar interaction. We verify the enhanced recruitment of the mutated peptide to the dynamic plus ends of MTs in a live-cell experiment. Our model explains EB1’s interaction with the SxIP-containing ligands and can be used to design small-molecule inhibitors blocking SxIP interaction with EB1.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>EB1</kwd><kwd>microtubules</kwd><kwd>MACF</kwd><kwd>cytoskeleton</kwd><kwd>NMR</kwd><kwd>exchange</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cwqg982</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>DTP</award-id><principal-award-recipient><name><surname>Hargreaves</surname><given-names>Eleanor</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04xs57h96</institution-id><institution>Liverpool University PhD studentship</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Almeida</surname><given-names>Teresa</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Structural analysis reveals a two-step EB1-SxIP binding mechanism and identifies ligand mutations that greatly enhance affinity, offering potential therapeutic avenues for targeting microtubule plus end interactions.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Microtubules (MTs) are fundamental to many cellular processes, such as intracellular transport, cell shape and organisation, polarity, and division. A large number of proteins are associated with MT functions, stabilising or destabilising MTs, guiding their growth or linking them to other cell components (<xref ref-type="bibr" rid="bib2">Akhmanova and Steinmetz, 2008</xref>; <xref ref-type="bibr" rid="bib17">Howard and Hyman, 2003</xref>). Plus end tracking proteins (+TIPs) are a very diverse group of proteins that accumulate at the growing (plus) ends of MTs. They form complex interaction networks that are fundamental to the MT dynamics and signalling properties. Disruption of plus end regulation in diseases like cancer can lead to abnormal cell division and migration, facilitating disease progression (<xref ref-type="bibr" rid="bib5">Aseervatham, 2020</xref>). Drugs targeting MTs are currently widely used in cancer therapies.</p><p>End binding protein 1 (EB1) is a key member of +TIPs networks that autonomously tracks the MT plus ends via its N-terminal CH domain. CH binding to MTs affects MT stability (<xref ref-type="bibr" rid="bib37">Zhang et al., 2015</xref>). EB1 dimerises through the C-terminal EB1c region, which increases EB1 affinity to MTs by the cooperative interaction of the two CH domains in the dimer (<xref ref-type="bibr" rid="bib29">Song et al., 2020</xref>). The EB1c region contains conserved EB1 homology (EBH) domain, which regulates +TIPs networks by recruiting a range of other +TIPs, such as cancer-related proteins APC and microtubule-actin cross-linking factor (MACF), through the interaction with the SxIP motifs (<xref ref-type="bibr" rid="bib15">Gouveia and Akhmanova, 2010</xref>; <xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>; <xref ref-type="bibr" rid="bib21">Kumar and Wittmann, 2012</xref>). These small four-residue conserved motifs are usually located in the intrinsically disordered regions of +TIPs (<xref ref-type="bibr" rid="bib9">Buey et al., 2012</xref>; <xref ref-type="bibr" rid="bib18">Jiang and Akhmanova, 2011</xref>).</p><p>The crystal structure of the EB1c dimer in complex with MACF SxIP peptide (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) showed that it forms a parallel leucine zipper coiled-coil dimer followed by a four-helix bundle of the EBH domain. The SxIP motif fits into a deep hydrophobic pocket of the EBH domain between the C-terminal loop and the long helices of the leucine zipper (<xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>). The conserved Ser forms a network of hydrophobic interactions, and Ile and Pro are embedded into a deep hydrophobic pocket; these interactions were proposed to be the main determinants of the ligand binding. The additional contributions of the non-SxIP residues into the binding have been shown through the systematic single-residue substitution analysis that highlighted the importance of the hydrophobic residues that immediately follow SxIP and the positive charges of the subsequent residues (<xref ref-type="bibr" rid="bib9">Buey et al., 2012</xref>). However, it has not been clear to what extent these residues change the overall affinity.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Residues that follow the SxIP motif enhance binding by engaging with the C-terminus of the EB1 EBH domain.</title><p>(<bold>A</bold>) Crystal structure of the EBH domain in the complex with microtubule-actin cross-linking factor (MACF) peptide (PDB ID 3GJO). EB1 is shown as a cartoon with the subunits of the dimer coloured in green and cyan, and a semi-transparent surface. The MACF peptide is coloured orange, with the SxIP motif chains-chains shown as sticks. The zoomed region highlights the binding pocket of EBH formed by the surface of the coiled-coil and the folded C-terminus. (<bold>B</bold>) Zoom on the partly formed SxIP binding pocket in the structure EBH domain free in solution (PDB ID 3EVI) in the same orientation as (<bold>A</bold>). The C-terminal region is unfolded. (<bold>C</bold>) EBH (50 µM) chemical shift changes in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra induced by 4MACF (blue, 100-fold excess), 6MACF (green, 100-fold excess), and 11MACF (red, 4-fold excess) peptides. (<bold>D</bold>) Relative intensities of cross-peaks (normalised to the intensity of the C-terminal residue G260) in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra of the EBH (50 µM) free in solution (black) and in the presence of 4MACF (blue, 100-fold excess), 6MACF (green, 100-fold excess), and 11MACF (red, 4-fold excess) peptides. (<bold>E</bold>) 'Dock-and-lock’ binding model that explicitly considers the role of EBH C-terminus in the interaction with the SxIP peptide. Initially, the binding pocket is partially formed and only contains SxIP-recognition region. Following the initial binding (‘dock’), the post-SxIP region of the peptide induces the folding of the of the C-terminus and formation of the full binding pocket (‘lock’). The deletion of the EBH C-terminus (orange) removes the ‘Lock’ stage of the binding, thus reducing the affinity of the interaction. The peptide is shown as a coloured bar, with red corresponding to the SxIP and blue to the post-SxIP regions.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Values of the chemical shift changes in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra induced by microtubule-actin cross-linking factor (MACF) peptides for <xref ref-type="fig" rid="fig1">Figure 1C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98063-fig1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Values of the relative intensities of cross-peaks (normalised to the intensity of the C-terminal residue G260) in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra of the EBH complexes with microtubule-actin cross-linking factor (MACF) peptides for <xref ref-type="fig" rid="fig1">Figure 1D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98063-fig1-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Post-SxIP residues increase the binding affinity.</title><p>(<bold>A, B, and C</bold>) Superposition of <sup>1</sup>H,<sup>15</sup>N-HSQC spectra of <sup>15</sup>N-labelled EBH domain of EB1 (50 µM) recorded at 600 MHz for the free form (black) and in the presence of the peptide (black), (<bold>A</bold>) 4MACF (5000 µM), (<bold>B</bold>) 6MACF (5000 µM), and (<bold>C</bold>) 11MACF (400 µM). The insets show changes in the spectra on the increase of the peptide concentration: (<bold>A</bold>) 250, 500, 1000, 2500, and 5000 µM of 4MACF, (<bold>B</bold>) 250, 500, 1000, 2500, and 5000 µM of 6MACF, and (<bold>C</bold>) 12.5, 25, 75, 82.5, 100, 125, 150, 200, and 400 µM of 11MACF. (<bold>D and E</bold>) Chemical shift changes (blue) of the residues with the largest induced shifts fitted into the single site binding model (red) to evaluate the dissociation constant K<sub>D</sub> for (<bold>D</bold>) 4MACF and (<bold>E</bold>) 6MACF. (<bold>F</bold>) Isothermal titration calorimetry (ITC) isotherm for the interaction of EBH with 11MACF (left) and 9MACF (right). The solid line shows the fitting of the data into a single-site binding model.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Mapping of the largest chemical shift changes induced by the peptide binding on the surface of EB1 EBH domain (<bold>A–C</bold>) and EBH EBH-ΔC (<bold>D–F</bold>) in the complex with the microtubule-actin cross-linking factor (MACF) peptide (green, shown in a stick representation).</title><p>The crystal structure was used to represent the complex (PDB ID 3GJO). The EBH C-terminus has been removed for EBHΔC. (<bold>A–C</bold>) Changes induced in the <sup>1</sup>H,<sup>15</sup>N-HSQC signals of EBH by (<bold>A</bold>) 4MACF, (<bold>B</bold>) 6MACF, and (<bold>C</bold>) 11MACF peptides. (<bold>D–F</bold>) Changes induced in the <sup>1</sup>H,<sup>15</sup>N-HSQC signals of EBHΔC by (<bold>D</bold>) 4MACF, (<bold>E</bold>) 6MACF, and (<bold>F</bold>) 11MACF peptides.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Deletion of the EBH C-terminus reduces the binding affinity.</title><p>(<bold>A</bold>,<bold> B</bold>, and <bold>C</bold>) Superposition of <sup>1</sup>H,<sup>15</sup>N-HSQC spectra of <sup>15</sup>N-labelled EBH-ΔC domain of EB1 (50 µM) recorded at 600 MHz for the free form (black) and in the presence of the peptide (black): (<bold>A</bold>) 4MACF (5000 µM), (<bold>B</bold>) 6MACF (5000 µM), and (<bold>C</bold>) 11MACF (400 µM). The insets show changes in the spectra on the increase of the peptide concentration: (<bold>A</bold>) 250, 500, 1000, 2500, and 5000 µM of 4MACF, (<bold>B</bold>) 250, 500, 1000, 2500, and 5000 µM of 6MACF, and (<bold>C</bold>) 12.5, 25, 75, 82.5, 100, 125, 150, 200, and 400 µM of 11MACF. (<bold>D</bold>) Chemical shift changes (blue) of the residues with the largest induced shifts fitted into a single-site binding model (red) to evaluate the dissociation constant K<sub>D</sub> for 6MACF. (<bold>E</bold>) Isothermal titration calorimetry (ITC) isotherm for the interaction of EBH with 11MACF. The solid line shows the fitting of the data into a single-site binding model. (<bold>F</bold>) Thermodynamic parameters (△G, blue; △H, red; –T△S, green) evaluated from the ITC data for the 11MACF binding to the EBH (left) and EBH△C (right).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig1-figsupp3-v1.tif"/></fig></fig-group><p>In the solution structure of free EB1c, the region corresponding to the C-terminal region is unstructured and dynamic, with the binding pocket only partially formed (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="bibr" rid="bib4">Almeida et al., 2017</xref>), leading to the conclusion that the binding of the MACF peptide induces the folding of the C-terminus to complete the binding pocket. However, we found that the 4-residue peptide SKIP fragment of MACF has a very low affinity to EBH and induces only small chemical shift changes in the <sup>1</sup>H,<sup>15</sup>N-HSQC, compared to an 11-residue MACF SxIP-containing peptide, demonstrating that post-SxIP residues have a critical contribution to the complex formation.</p><p>Here, we characterise the mechanism and outline the structural features of EBH interactions with the MACF-derived SxIP peptides using biophysical techniques such as NMR and isothermal titration calorimetry (ITC). We show that the post-SxIP residues induce the folding of the EBH C-terminus, thus making a large additional contribution to the peptide binding. To evaluate this contribution, we propose a two-step ‘dock-and-lock’ model for the peptide interaction with EBH, where the SxIP motif initially docks into the partly formed binding pocket, which subsequently induces the C-terminus folding. Using systematic modifications of EBH and the peptide, we evaluate the thermodynamic and kinetic parameters of the binding. We dissect the contributions of the different peptide regions into the binding and design a peptide with nanomolar affinity to EBH. Our model can be used for the prediction of the EBH affinity to different natural ligands and as a rationale for the design of small molecules to inhibit EB1 interactions that have a recognised contribution to human neoplastic diseases such as cancer (<xref ref-type="bibr" rid="bib1">Abiatari et al., 2009</xref>; <xref ref-type="bibr" rid="bib22">Liu et al., 2009</xref>).</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>SxIP gives specificity in binding to EB1, but flanking residues strengthen the interaction</title><p>For the analysis, we selected an EB1 fragment that was previously used by Honnappa et al. to solve crystal structure of the EBH complex with MACF peptide (<xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>). This fragment has a deletion of eight C-terminal residues (D257-G260) that are dynamic and not involved in the ligand binding, as the authors showed by the NMR analysis. For clarity, we use the EBH abbreviation for the 8-residue truncated fragment (residues D191-G260) and EBH-ΔC for the fragment (D191-G252) with an additional 8-residue C-terminal truncation. While the EBH domain was initially associated with a smaller region N223-G252, the structure of the EBH/MACF complex (<xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>) showed a continuous long coiled-coil integrated with the EBH 4-helix bundle and partial folding of the C-terminal region (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Thus, structurally, EB1 is better described as having a single, extended EBH domain (residues D257-G260) that contains binding site for SxIP ligands at the interface of the 4-helical and coiled-coil parts of the structure.</p><p>Our previous analysis suggested that the folding of the C-terminus induced by the SxIP peptide is required for high binding affinity (<xref ref-type="bibr" rid="bib4">Almeida et al., 2017</xref>). To investigate the roles of different peptide regions in the folding of the C-terminus and the connection between folding and affinity, we compared the binding of the 4- and 6-residue fragments, SKIP (4MACF) and SKIPTP (6MACF), with the 11-residue MACF peptide KPSKIPTPQRK (11MACF) that was used to solve the crystal structure of the complex (<xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>). These peptides induced progressively larger changes in the NMR spectra of the <sup>15</sup>N-labelled EBH domain (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). For 4MACF and 6MACF, we observed fast exchange between the free and bound states, characterised by a progressive linear change of the chemical shifts in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra of EBH on peptide addition. This corresponds to a weak EBH interaction with the peptides. Fitting the chemical shift changes into a two-state binding model (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D and E</xref>) estimates the dissociation constant K<sub>D</sub> of the binding as ~10 mM and ~2 mM for 4MACF and 6MACF (<xref ref-type="table" rid="table1">Table 1</xref>), respectively, similar to the K<sub>D</sub> values we measured previously for the SxIP-like molecules (<xref ref-type="bibr" rid="bib4">Almeida et al., 2017</xref>). For the 11MACF peptide, many signals are in the slow exchange regime, in agreement with a much stronger interaction (K<sub>D</sub> 3.5 ± 1.0 µM from ITC, <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). To understand the dramatic effect on the interaction of the non-SxIP residues, we investigated the contributions of these residues to the binding further.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Binding parameters of the EB1 homology (EBH) domain interactions with peptides.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top"/><th align="left" valign="top">K<sub>D</sub>(µM)<xref ref-type="table-fn" rid="table1fn2">*</xref></th><th align="left" valign="top">ΔG(kJ/mol)</th><th align="left" valign="top">ΔH(kJ/mol)</th><th align="left" valign="top">–TΔS(kJ/mol)</th><th align="left" valign="top">N sites</th><th align="left" valign="top">k<sub>off</sub>(s<sup>–1</sup>)<xref ref-type="table-fn" rid="table1fn3"><sup>†</sup></xref></th><th align="left" valign="top">k<sub>on</sub>(µM<sup>–1</sup> s<sup>–1</sup>)</th></tr></thead><tbody><tr><td align="left" valign="top">EBH/4MACF</td><td align="left" valign="top">(10400±280)</td><td align="left" valign="top">(–11.312±0.066)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">EBH/6MACF</td><td align="left" valign="top">(1730±240)</td><td align="left" valign="top">(–15.76±0.34)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">EBH/9MACF</td><td align="left" valign="top">34.00±0.56</td><td align="left" valign="top">–25.49±0.04</td><td align="left" valign="top">–24.95±0.06</td><td align="left" valign="top">–0.52±0.1</td><td align="left" valign="top">1.00±0.04</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">EBH/11MACF</td><td align="left" valign="top">3.5±1.0 (4.91±0.09)</td><td align="left" valign="top">–31.20±0.81</td><td align="left" valign="top">–39.6±4.5</td><td align="left" valign="top">8.4±3.6</td><td align="left" valign="top">1.13±0.17</td><td align="left" valign="top">130.2±2.1 (143.6±6.0)</td><td align="left" valign="top">37±11</td></tr><tr><td align="left" valign="top">EBH/11MACF-LLL</td><td align="left" valign="top">0.287±0.088</td><td align="left" valign="top">–37.50±0.87</td><td align="left" valign="top">–35.8±5.3</td><td align="left" valign="top">–4.9±1.4</td><td align="left" valign="top">1.01±0.11</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">EBH/11MACF-VLL</td><td align="left" valign="top">0.081±0.009 (0.32±0.012)</td><td align="left" valign="top">–40.50±0.25</td><td align="left" valign="top">–40.2±1.2</td><td align="left" valign="top">–1.300±0.091</td><td align="left" valign="top">0.906±0.056</td><td align="left" valign="top">15.63±0.12 (57.5±8.7)</td><td align="left" valign="top">192±21</td></tr><tr><td align="left" valign="top">EBH/11MACF-VLLRK</td><td align="left" valign="top">0.016±0.003</td><td align="left" valign="top">–44.60±0.47</td><td align="left" valign="top">–27.80±0.30</td><td align="left" valign="top">–16.80±0.32</td><td align="left" valign="top">1.18±0.14</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">EBH/11MACF-VLLRK150 mM NaCl</td><td align="left" valign="top">0.198±0.012</td><td align="left" valign="top">–38.5±1.5</td><td align="left" valign="top">–34.4±1.8</td><td align="left" valign="top">–4.18±0.17</td><td align="left" valign="top">1.03±0.05</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">EBH/13CK5P2</td><td align="left" valign="top">0.021±0.022</td><td align="left" valign="top">–46.4±5.0</td><td align="left" valign="top">–36.4±8.8</td><td align="left" valign="top">–9.6±5.0</td><td align="left" valign="top">0.876±0.093</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">EBH-△C/6MACF</td><td align="left" valign="top">(7070±1880)</td><td align="left" valign="top">(–12.27±0.66)</td><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">EBH-ΔC/11MACF</td><td align="left" valign="top">41.5±8.8 (26.6±0.51)</td><td align="left" valign="top">–24.62±1.7</td><td align="left" valign="top">–29.1±1.8</td><td align="left" valign="top">1.11±0.92</td><td align="left" valign="top">1.08±0.35</td><td align="left" valign="top">1900±54</td><td align="left" valign="top">45.8±9.8</td></tr><tr><td align="left" valign="top">EBH-ΔC/11MACF-VLL</td><td align="left" valign="top">18.7±3.1 (25.62±0.82)</td><td align="left" valign="top">–27.00±0.43</td><td align="left" valign="top">–24.9±4.5</td><td align="left" valign="top">–2.1±4.8</td><td align="left" valign="top">0.99±0.18</td><td align="left" valign="top">1541±79</td><td align="left" valign="top">82±14</td></tr><tr><td align="left" valign="top">EBH-ΔC/11MACF-VLLRK</td><td align="left" valign="top">6.29±0.47</td><td align="left" valign="top">–29.70±0.17</td><td align="left" valign="top">–24.6±4.6</td><td align="left" valign="top">–5.1±4.6</td><td align="left" valign="top">0.960±0.056</td><td align="left" valign="top"/><td align="left" valign="top"/></tr></tbody></table><table-wrap-foot><fn><p>All experiments were conducted in the buffer containing 50 mM phosphate (pH 6.5), 50 mM NaCl, 0.5 mM TCEP, and 0.02% NaN<sub>3</sub>. Salt concentration was increased to 150 mM NaCl for EBH/11MACF-VLLRK (marked in the table) to test the ionic strength dependence of the binding.</p></fn><fn id="table1fn2"><label>*</label><p>K<sub>D</sub> is determined by ITC and NMR (values in brackets). Average over three technical replicates and standard deviation is reported for ITC. The dissociation constants for 4MACF and 6MACF were determined by fitting chemical shift perturbations; average values over the peaks with the largest perturbations and standard deviation are reported. For other peptides, the NMR binding parameters were determined by the lineshape analysis in TITAN software; the results of the global fit over the well-resolved signals with the largest chemical shift perturbation (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>) and standard deviation from the fit are reported.</p></fn><fn id="table1fn3"><label>†</label><p>k<sub>off</sub> is determined by the NMR lineshape analysis (standard deviation reported) and CEST (values in brackets with standard deviations from the fit).</p></fn></table-wrap-foot></table-wrap><p>The chemical shift changes in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra for the peptides map to increasingly larger regions on the EBH surface (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Notably, the changes for the 4- to 6-residue peptides are located predominantly in the structured part of EBH, with relatively small effect on the unstructured C-terminal region. In contrast, the 11-residue peptide induced the largest chemical shift perturbations in the C-terminal region (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). Additionally, we observed a different effect on the intensities of the <sup>1</sup>H,<sup>15</sup>N-HSQC cross-peaks assigned to the C-terminal region of EBH from the addition of the peptides (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). In the free EBH, the intensity of the signals of the C-terminal region E251-G260 is much higher than the signals of the coiled-coil part of the protein, as expected for the dynamical C-terminus. In the presence of the 4- and 6-residue peptides, the intensities of these signals still remain much higher than the signals corresponding to the coiled-coil part folded part of EBH, while in the presence of the 11-residue peptide, the intensities of many C-terminal signals became similar to those of the folded part, corresponding to partial immobilisation of the C-terminus. The combination of the chemical shift and intensity changes suggests that the folding of the C-terminal regions seen in the crystal structure of the complex is induced not by the SxIP motif, but by the residues that follow it, and that this folding leads to the much higher binding affinity. While not conserved in the ligand sequence and not defining ligand specificity (<xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>), the post-SxIP residues clearly have a critical role in the interaction.</p><p>The intensities of the last four C-terminal residues of EBH (residues D257-G260) remain high even in the complex with the 11MACF peptide, and this region shows no chemical shift changes. This demonstrates that the final residues of the EBH remain dynamic in the complex and are not involved in the interaction with the ligand. This aligns with the conclusion of <xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>, that the end of the EB1c C-terminal region (residues P261–268) is not required for the ligand binding and can be removed.</p><p>The 11MACF peptide has a 2-residue extension at the N-terminus compared to 4MACF and 6MACF. Deletion of these residues in the 9MACF peptide SKIPTPQRK led to the increase of K<sub>D</sub> measured by ITC to 34.00 ± 0.56 µM (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>), showing significant contribution of the pre-SxIP region into the binding. Thus, both SxIP flanking regions are important for the binding affinity despite their low conservation, with a dominating effect from the post-SxIP region.</p><p>To define the contribution of the EBH C-terminus, we analysed peptide binding to the EBH-ΔC fragment lacking the C-terminal SxIP binding region. For the signals of the EBH-ΔC coiled-coil region, we observed similar changes on peptide addition as in the EBH spectra; however, the amplitudes of the changes were reduced, corresponding to much weaker interactions (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A–C</xref>). For the 4MACF peptide, the interactions were too weak to estimate K<sub>D</sub>, while the affinities to 6MACF and 11MACF are reduced 4- and 10-fold, respectively (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3D and E</xref> and <xref ref-type="table" rid="table1">Table 1</xref>). The ITC thermodynamic parameters show that for 11MACF, the reduction in the affinity is caused by the large decrease of the absolute value of the interaction enthalpy, partly compensated by the reduction of the entropy loss (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3F</xref>). This agrees with the partial loss of the binding pocket and the lack of the additional ordering of the unstructured C-terminus, as the residues that become immobilised in the complex are missing. Notably, chemical shift perturbations in the coiled-coil part of EBH are less extensive for the 11MACF (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2F</xref>), indicating that in the absence of the fully formed binding pocket, the C-terminal region of the peptide has a reduced contact with the coiled-coil region.</p><p>The above observations support a ‘dock-and-lock’ model for the SxIP binding where the SxIP-motif itself only provides the initial recognition, while the full affinity of the interaction is controlled by the folding of the EBH unstructured C-terminal, leading to the additional interactions with the peptide residues immediately following the SxIP motif (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). To validate this model, we analysed the solution structure of the EBH/MACF complex and measured the interaction dynamics for a series of peptides.</p></sec><sec id="s2-2"><title>Peptide binding changes the structure and dynamics of the EBH C-terminus</title><p>Following the 11MACF binding, chemical shifts of the EBH C-terminal signals change dramatically and their intensity becomes comparable to the signals on the structured regions of EBH (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>). To relate the changes in the spectra to the structural rearrangement on binding in solution, we solved the NMR structure of EBH following the methodology described in <xref ref-type="bibr" rid="bib4">Almeida et al., 2017</xref>. For the coiled-coil EBH region that is structured in the free form (leucine zipper and the 4-helix bundle), we observed a similar pattern of intra- and inter-molecular contacts in the complex, and similar values of the dihedral angles derived from the <sup>13</sup>C-chemical shifts as for the free EBH. In contrast, a large number of new intra-molecular contacts were detected in the C-terminal regions, as well as the inter-molecular contacts between the 11MACF peptide and EBH. This directly demonstrates that the peptide binding has a limited effect on the overall fold of EBH, and most of the structural changes occur in the C-terminal region.</p><p>The solution structure determined from the NMR data shows that EBH in the complex with 11MACF has a coiled-coil structure consisting of a leucine zipper and a four helical bundle in the upper region that is practically identical to the structure of the free form (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The C-terminus folds over the peptide (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), forming a loop similar to the loop observed in the crystal form (<xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>). Only a small number of contacts were detected for the N-terminal KPSK region of the peptide, including Ser5477, that shows a single distance contact to Phe218. This suggests a limited role of this region in the interaction with EBH. Interestingly, an extensive H-bond network involving Ser5477 has been identified in the crystal structure (<xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>). The lack of NOE contacts of Ser5477 suggests that H-bonds in solution are transient and play less significant structural role than has been expected from the crystal structure. The following residue, Lys5478, is solvent exposed and has no NOE contacts with the helical part of EBH. In contrast, the side-chain Ile5479 shows the largest number of NOE distance contacts to the residues of coiled-coil part of EBH, including Tyr217, Phe218, Leu221, Arg222, Ile224, Glu225, Leu246, and Tyr247. The side chains of these residues form a deep hydrophobic pocket that matches the shape of Ile. Similarly, Pro5480 shows hydrophobic contacts to Tyr217, Phe218, and further down with Thr249. Both Pro5480 and Thr5481 engage with the lower region of the 4-helix bundle, just below the SxIP binding site, with NOEs to the aromatic patch <sup>216</sup>FYF<sup>218</sup>.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Structure and dynamics of the EB1 EB1 homology (EBH) domain.</title><p>(<bold>A</bold>) Superposition of 20 NMR structures calculated for EBH in the complex with 11MACF peptide (left). Previously reported NMR structures of the free EBH (PDB ID 6EVI, middle) and the EBH complex with a small SxIP-like molecule 1a (PDB ID 6EVI, right) are shown for comparison. The EBH subunits are coloured in green and cyan, the peptide and the small molecule in orange and magenta. (<bold>B</bold>) Representation of the residues forming the contact interface between the EBH and 11MACF peptide, both shown as cartoon, with side chain displayed for all the residues involved in the contacts between the two molecules. EB1 is coloured in grey and 11MACF in green, with oxygen shown in red and nitrogen shown in blue. (<bold>C</bold>) Order parameters S<sup>2</sup> (left) and exchange contributions into the relaxation rate R<sub>ex</sub> (right) calculated from the relaxation parameters for the free EBH (top) and EBH in complex with 11MACF peptide (bottom) mapped on the EBH solution structure. The thickness of the tube is proportional to 1 S<sup>2</sup> (left) or R<sub>ex</sub> (right).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Relaxation parameters measure at 600 (blue) and 800 (orange) MHz for free EB1 homology (EBH) (left) and EBH in the complex with 11MACF (right).</title><p>From top to bottom: relaxation rates R1, R2, ratio R2/R1, <sup>1</sup>H-<sup>15</sup>N NOE, and isotropic correlation time <inline-formula><alternatives><mml:math id="inf1"><mml:msubsup><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>o</mml:mi></mml:mrow></mml:msubsup></mml:math><tex-math id="inft1">\begin{document}$\tau _{c}^{iso}$\end{document}</tex-math></alternatives></inline-formula> directly calculated for each residue using isotropic model. The secondary structure of the EBH domain is shown schematically at the bottom.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Values of relaxation parameters for the free EB1 homology (EBH) and EBH complex with 11MACF peptide.</title></caption><media mimetype="text" mime-subtype="plain" xlink:href="elife-98063-fig2-figsupp1-data1-v1.txt"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Order parameters S<sup>2</sup> and exchange rates R<sub>ex</sub> calculated from the relaxation data for free EB1 homology (EBH) (left) and EBH in complex with the 11MACF peptide (right).</title><p><supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Calculated S<sup>2</sup> and R<sub>ex</sub> parameters for the free EB1 homology (EBH) and EBH complex with 11MACF peptide.</title></caption><media mimetype="text" mime-subtype="plain" xlink:href="elife-98063-fig2-figsupp2-data1-v1.txt"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig2-figsupp2-v1.tif"/></fig></fig-group><p>Additionally, the <sup>5480</sup>PT<sup>5481</sup> part of the peptide makes numerous contacts with the folded hydrophobic region <sup>253</sup>FVIP<sup>256</sup> of the C-terminus (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). These interactions position the C-terminus in the linear conformation on top of the peptide, protecting it from the solvent. The aromatic ring of Phe253 in the EBH C-terminus slots between the two Pro residues of the peptide and stacks against the ring of Phe261 of the coiled-coil region, anchoring the folded loop to the EBH core. This is the only direct interaction between the C-terminus and the EBH core; in the absence of the peptide, it would be insufficient to stabilise the structure of the C-terminus. This agrees with the lack of EBH C-terminal folding in the complexes with the shorter MACF peptides (see above).</p><p>To assess the dynamic properties of the loop in the free EBH and the peptide complex, we measured <sup>15</sup>N relaxation at 600 and 800 MHz NMR fields, which gives information on both slow and fast exchange processes. At both magnetic fields, the relaxation parameters showed matched sequence distribution profiles (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). The elevated R2/R1 ratios and NOE values, corresponding to the low internal mobility, are located in the helical regions of EBH structure, while the reduced values, corresponding to the high dynamics, are in the loop between the helices and the EBH C-terminus (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). The order parameter S<sup>2</sup> that quantitatively characterises the fast motion and the exchange contribution into the relaxation R<sub>ex</sub> that characterises slow structural rearrangements (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>) has been derived by the model-free analysis in the Relax software (<xref ref-type="bibr" rid="bib12">d’Auvergne and Gooley, 2008</xref>). Mapping of these values on the EBH structure (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) shows that in the free EBH, the whole C-terminus is highly dynamic, in agreement with the variations in the NMR structures and high intensities of the <sup>1</sup>H,<sup>15</sup>N-HSQC cross-peaks. Surprisingly, high dynamics is also observed in the loop between the helices that is well determined in the NMR structures. This discrepancy is likely caused by the multiple conformations of the loop leading to partially contradicting NMR restraints. In such cases, the NMR structures represent an averaged conformation. In the EBH/11MACF complex, only the last four residues are dynamic; the rest of the C-terminus is fully immobilised. Notably, the S<sup>2</sup> values of the C-terminal loop in EBH (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>) are very close to the values in the helical parts, demonstrating that the structure of the C-terminus in the complex is rigid despite the high initial dynamics of the C-terminus of free EBH and the free peptide in solution. Surprisingly, the low values of R<sub>ex</sub> show the lack of slow conformational changes in the immobilised C-terminus that are often observed in similar systems. Once formed, the complex is very rigid, suggesting well-matching structures of the peptide and the EBH C-terminus.</p><p>The structural and dynamics analysis supports a two-step model of the SxIP peptide binding (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). In the free form, only the SxIP-recognition part of the binding pocket is formed that allows the initial docking of the peptide predominantly through the hydrophobic interaction of Ile5479. These interactions are insufficient for strong binding because they involve only a small number of the peptide residues. The initial docking induces the folding of the EBH C-terminus through the complementarity between the hydrophobic region <sup>253</sup>FVIP<sup>256</sup> of the C-terminus and the peptide residues that immediately follow the SxIP motif. The folded C-terminus is fixed to the coiled-coil region through the aromatic stacking of Phe253 and Phe261. The additional interactions induced by the folding of the C-terminus extend the binding pocket and increase the affinity ~20-fold, based on the EBH C-terminal deletion experiments. Next, we used the binding model to design peptides with enhanced binding affinity and to dissect contributions from different peptide regions to the binding.</p></sec><sec id="s2-3"><title>Peptide optimisation in the post-SxIP region</title><p>The folding of the EBH C-terminus after the peptide binding brings the highly hydrophobic region <sup>253</sup>FVIP<sup>256</sup> of EBH into contact with a relatively hydrophilic <sup>5481</sup>TPQ<sup>5483</sup> region of the peptide (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We reasoned that the affinity of the interaction can be enhanced by making this area of the peptide more hydrophobic. To assess a suitable substitution, we docked three versions of the modified peptides into the EBH structure of the complex with MACF: KPSKIP<underline>LLL</underline>RK (11MACF-LLL), KPSKIP<underline>VLL</underline>RK (11MACF-VLL), and KPSKP<underline>ILL</underline>RK (11MACF-ILL) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). All variants showed a high complementarity to the binding site. The highest fitness score was obtained for 11MACF-LLL, followed by 11MACF-VLL. The score of 11MACF-ILL was similar to that of the wild-type. Based on the docking, KPSKIP<underline>LLL</underline>RK and KPSKIP<underline>VLL</underline>RK were selected for the experimental analysis.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Enhancement of the peptide binding through the substitution of the post-SxIP residues.</title><p>(<bold>A</bold>) Folding of the C-terminus brings the hydrophobic EB1 homology (EBH) residues of that region into contact with the TPQ region of the peptide. Structure of the free EBH (left) and EBH in the complex with 11MACF (right). (<bold>B</bold>) Proximity of the positively charged RK residues of the peptide to the negatively charged patch on the EBH surface. The peptide is shown as a cartoon, RK side chains are shown in a stick representation. Positive and negative electrostatic surface potential is represented by blue and red colour, respectively. (<bold>C</bold>) The isothermal titration calorimetry (ITC) titration (top) and the binding isotherm fitted into a single-site binding model (bottom) of the ITC binding experiments for the 11MACF peptide and the mutants 11MACF-LLL, 11MACF-VLL, and 11MACF-VLLRK. The peptide sequences are shown above the graphs, with the changed regions highlighted by the red (mutation) and green (insertion) colours. (<bold>D</bold>) The thermodynamic parameters ∆G (green), ∆H (blue), and –T∆S (red) calculated from the isothermal titration calorimetry (ITC) data.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Values of the thermodynamic parameters for <xref ref-type="fig" rid="fig3">Figure 3D</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98063-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Best scored docking poses obtained for (<bold>A</bold>) 11MACF-WT, (<bold>B</bold>) 11MACF-LLL, (<bold>C</bold>) 11MACF-VLL, and (<bold>D</bold>) 11MACF-ILL.</title><p>The EB1 homology (EBH) structure is shown as a semi-transparent grey surface and cartoon. The peptide is shown in stick representation. Carbon atoms are coloured in magenta, oxygen is shown in red, and nitrogen in blue. Hydrogen bonds are shown as yellow dashed lines and hydrophobic interaction regions are highlighted by green dashed lines. The SxIP region is boxed.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig3-figsupp1-v1.tif"/></fig></fig-group><p>The ITC titration curves (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="table" rid="table1">Table 1</xref>) of the WT and the mutants had a sigmoid curve with a single inflection point and fitted to a single site model without any systematic deviation between the fitted curve and the experimental data. The stoichiometric molar ratio was close to one peptide molecule to one EB1c monomer, in agreement with two peptide binding sites in the EB1c dimer and no cooperativity between them. We observed a 10-fold increase in binding affinity for 11MACF-LLL and a further 3-fold increase for 11MACF-VLL, when compared with the wild-type 11MACF. Notably, the enthalpy of the interaction of the 11MACF-LLL variant is lower than for the WT and 11MACF-VLL (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), suggesting a less optimal match to the binding pocket. This is compensated by a favourable change in the entropy, implying an increased hydrophobic effect, as predicted by the modelling. The binding enthalpy for 11MACF-VLL was similar to the WT, indicating a good fit to the binding pocket. The change in the entropy is less favourable than for 11MACF-LLL, agreeing with the reduced hydrophobicity. However, the net change in the negative free energy is larger for 11MACF-VLL, explaining the affinity increase.</p><p>The positively charged RK region at the C-terminus of the peptide does not make any stable contacts with EBH. However, this part of the peptide is close to the negatively charged patch on the EBH surface (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). We speculated that this proximity creates a favourable electrostatic interaction, enhancing the affinity of the peptide. To test this prediction, we duplicated the RK sequence at the C-terminus in the extended peptide KPSKIP<underline>VLL</underline>RK<underline>RK</underline>(11MACF-VLLRK). In agreement with the prediction, ITC showed a further 5-fold increase in affinity, leading to K<sub>D</sub> of 16 ± 3 nM (<xref ref-type="table" rid="table1">Table 1</xref>). Overall, through the rational sequence modification, we enhance the affinity by nearly two orders of magnitude, changing the binding from the micromolar to nanomolar range.</p><p>Comparison of the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra of EBH in the free form and different EBH complexes reflects the structural changes associated with the changes in affinity (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). The binding of the WT 11MACF leads to the large changes in the positions of the signals of the residues in the binding site through the direct contact. Additionally, the peptide induces the folding of the C-terminus, introducing even larger changes to the corresponding signals. Because of the extensive interaction between EBH and the peptide, nearly all <sup>1</sup>H,<sup>15</sup>N-HSQC signals change position in the complex. Modification from TPQ to LLL results in further large chemical shift changes, primarily in the signals of the folded hydrophobic part of the C-terminus (<sup>253</sup>FVIP<sup>256</sup>) that interacts with the modified peptide region, and of Phe218 that forms an aromatic stacking contact with Phe253. No significant changes are observed in the signals of the residues forming the SxIP binding site. This suggests structural rearrangement of the C-terminus to match the modified, more hydrophobic peptide sequence. On the LLL to VLL change in 11MACF-VLL, the spectral changes are much smaller and in the same C-terminal EBH region, demonstrating further, small structural rearrangements. The addition of the positively charged RK residues in 11MACF-VLLRK has a minimal effect on the spectra, indicating that the contacts of the charged residues are transient.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Exchange rates and binding energies for the interaction of EB1 homology (EBH) domain with the SxIP ligands.</title><p>(<bold>A</bold>) 11MACF-LLL and 11MACF-VLL peptides induce increased chemical shift changes compared to the 11MACF. Chemical shift differences in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra between the free EBH and the EBH/11MACF complex (blue), EBH/11MACF and EBH/11MACF-LLL (orange), and EBH/11MACF and EBH/11MACF-VLL (green). (<bold>B</bold>) Chemical shift changes in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra on peptide addition observed for the EBH interactions with different peptides illustrated for the Thr<sup>249</sup> signal. Superposition of the spectra for the titration of the EBH-ΔC with 11MACF (left), EBH with 11MACF (middle), and EBH with 11MACF-VLL (right). Signals of the free EBH are shown in red, fully bound EBH in blue, and the intermediate titration points are shown in the pale colours. Notice two additional signals that are observed for the EBH/11MACF-VLL titration at the intermediate concentrations corresponding to the non-symmetrical form where EBH dimer binds a single peptide. These signals can only be observed when the exchange between the different forms is very slow. (<bold>C</bold>) Example of the chemical exchange saturation transfer (CEST) profiles measured for the EBH/11MACF interaction at the irradiation field strength of 12.5, 25, and 50 Hz (left to right) for Asp<sup>250</sup>. Solid curve represents the fitting of the data into the global exchange model with the dissociation rate 143.6 s<sup>–1</sup> calculated with Chemix software. (<bold>D</bold>) Exchange rates calculated for the EBH interaction with 11MACF peptide from the combination of the NMR data using the two-stage interaction model, where the folding of the EBH C-terminus follows the peptide binding. (<bold>E</bold>) Free energy contributions into the EBH interaction with the 11MACF peptide (left) and the mutated 11MACF-VLL peptide (right). The SxIP motif itself contributes approximately half of the binding energy (–19.9 kJ/mol), with the second half created by the interaction of the KP and TPQRK regions. The C-terminal EBH region that folds on the peptide contributes –6.6 kJ/mol into the binding. The VLL mutation increases the overall contribution of non-SxIP residues into the binding energy to –28.4 kJ/mol, and the binding energy of the EBH C-terminus to –13.5 kJ/mol.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Values of the chemical shift changes in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra induced by microtubule-actin cross-linking factor (MACF) peptides for <xref ref-type="fig" rid="fig4">Figure 4A</xref>.</title></caption><media mimetype="text" mime-subtype="plain" xlink:href="elife-98063-fig4-data1-v1.txt"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Progressive changes in the HSQC spectra in the complexes with the mutant peptides.</title><p>Superposition of (<bold>A</bold>) the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra of free EBH (blue) and EB1/11MACF complex (red), (<bold>B</bold>) EB1/11MACF (blue) and EB1/11MACF-LLL (red) complex, (<bold>C</bold>) EB1/11MACF-LLL (blue) and EB1/11MACF-VLL (red) complex, and (<bold>D</bold>) EB1/11MACF-VLL (blue) and EB1/11MACF-VLLRK (red) complex. The SxIP region is underlined and the modified post-SxIP region is highlighted in blue. Signals corresponding to the <sup>253</sup>FVI<sup>255</sup> region are labelled in the spectra, with colours corresponding to the spectrum.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Sequence alignment and interactions of SxIP motifs.</title><p>(<bold>A</bold>) Sequence alignment of known SxIP proteins showing large variation of non-SxIP residues. Sequence conservation and consensus sequence are presented at the bottom. Residues are colour-coded according to the properties of the side chains. The figure was created with JalView. (<bold>B, C</bold>) Isothermal titration calorimetry (ITC) isotherm for the interaction of EBH with 13MACF (<bold>B</bold>) and CK5P2 (<bold>C</bold>). The solid line shows the fitting of the data into a single-site binding model.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Progressive changes in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra on peptide addition observed for different EB1 interactions that were used to evaluate the exchange rates with TITAN software for the corresponding EB1 homology (EBH) complexes.</title><p>Superposition of the spectra for the titration of (<bold>A</bold>) EBH-ΔC with 11MACF, (<bold>B</bold>) EBH-ΔC with 11MACF-VLL, (<bold>C</bold>) EBH with 11MACF, and (<bold>D</bold>) EBH with 11MACF-VLL. Signals of the free EBH are shown red, final titration point in blue, and the intermediate titration points are shown in the pale colours. Notice additional signals that are observed for EBH/11MACF-VLL titration at the intermediate concentrations corresponding to the non-symmetrical form where the EBH dimer binds a single peptide. These signals can only be observed when the exchange between different forms is very slow.</p><p><supplementary-material id="fig4s3sdata1"><label>Figure 4—figure supplement 3—source data 1.</label><caption><title>Values of the chemical exchange saturation transfer (CEST) measurements for EBH/11MACF complex for <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-98063-fig4-figsupp3-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig4-figsupp3-v1.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Chemical exchange saturation transfer (CEST) profiles for the residues with the <sup>15</sup>N chemical shift differences between the signals of the free and the bound states larger than 1 ppm.</title><p>(<bold>A</bold>) Summary of the CEST profiles observed for EBH/11MACF interaction at the irradiation field strength of 12.5 (blue), 25 (orange), and 50 Hz (green). (<bold>B</bold>) Illustration of the CEST profile fitting (solid line) into the global exchange model with the dissociation rate 120 s<sup>–1</sup> calculated with Chemix software.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig4-figsupp4-v1.tif"/></fig></fig-group><p>Taking ITC and NMR data together, the described peptide modifications optimise the property of the post-SxIP region for high affinity. The residues immediately following SxIP are engaged in the hydrophobic interactions and have to match the complementary FVIP region of EBH. This region is initially unstructured, allowing it to fit different peptide sequences. The closer fit would increase the affinity; however, the specificity of these interactions is limited because the flexible C-terminus can adapt to different sequence. This is reflected in the low sequence conservation beyond the SxIP motif (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). Additional, smaller contributions to the affinity come from the non-specific charge interactions between the positive C-terminus and the negative surface of EBH. The separation of the specificity and affinity of the peptide binding shows that different sets of interaction control each stage of the dock-and-lock model (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Additionally, the transition to the full complex (lock) depends on the kinetics of C-terminus folding induced by the post-SxIP region of the peptide. To evaluate the kinetic parameters and to develop the binding model further, we investigated the kinetics of the EBH interaction with WT and modified MACF peptides.</p></sec><sec id="s2-4"><title>Kinetics of the target peptide recognition by EBH</title><p>NMR spectroscopy provides a diversity of methods to measure exchange processes at a wide range of timescales (<xref ref-type="bibr" rid="bib14">Furukawa et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Camacho-Zarco et al., 2022</xref>). The <sup>15</sup>N relaxation analysis (see above) demonstrates the lack of fast and slow conformational changes in the folded EBH regions both in the free form and in the complex with 11MACF (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). This suggests a low population of the intermediate ‘dock’ state and/or fast transition to the final ‘lock’ state of the binding model (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). This conclusion is further supported by the lack of the exchange contribution in the relaxation dispersion experiments even for the residues with the largest chemical shift changes of ~2000 Hz (data not shown). This prevents us from the direct evaluation of the kinetic parameters for the exchange between the ‘lock’ and the ‘dock’ stages. However, the parameters for the initial peptide docking can be measured with the truncated EBH-ΔC, where the C-terminal hydrophobic residues that contact post-SxIP region of the peptide are removed. Then, the kinetic parameters of the second ‘lock’ stage can be estimated from the overall exchange rate in the presence of the C-terminus.</p><p>The effect of the chemical exchange is clearly manifested in the exchange broadening of the EBH signals in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra in the course of the titrations (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). To evaluate the exchange rates, we fitted the spectral changes into the exchange model using TITAN software (<xref ref-type="bibr" rid="bib35">Waudby et al., 2016</xref>). Large changes in the EBH chemical shifts that are observed in many signals on binding allow probing a wide range of the exchange rates for different regions of EBH (see Appendix 1 for more information on the TITAN analysis).</p><p>For the quantitative binding analysis in the TITAN software, we selected non-overlapped signals with clear changes in the peak amplitude and position in the course of the titration (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). When spectral changes were fitted independently for each residue, the <inline-formula><alternatives><mml:math id="inf2"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft2">\begin{document}$K_{D}$\end{document}</tex-math></alternatives></inline-formula> values and exchange rates were similar, indicating that binding kinetics is similar for different regions of the binding site. We therefore used a global fitting of all signals to evaluate the overall kinetic parameters of the binding. The <inline-formula><alternatives><mml:math id="inf3"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:math><tex-math id="inft3">\begin{document}$K_{D}$\end{document}</tex-math></alternatives></inline-formula> values obtained independently from the TITAN lineshape analysis were similar to the value measured by ITC (<xref ref-type="table" rid="table1">Table 1</xref> and Appendix 1 information), validating the NMR analysis. The fitting of the EBH/11MACF and EBH-ΔC/11MACF-VLL data required the use of the dimer binding model. For the WT peptide, this model showed no cooperativity between the two binding sites in the dimer, while a weak negative cooperativity has been detected for the 11MACF-VLL peptide binding. This conclusion was not supported by the ITC data that showed no bi-phase features in the titration profile and consistent fit to the single site model. This demonstrates that the effect of the cooperativity on the binding constant is too small to be detected by ITC and unlikely to have a functional consequence.</p><p>The dissociation rate of 130.2 ± 2.1 s<sup>–1</sup> evaluated for the EBH/11MACF interaction with TITAN is optimal for the chemical exchange saturation transfer (CEST) NMR experiments, where saturation is transferred from the high-population free state to the low-population complex (<xref ref-type="bibr" rid="bib32">Vallurupalli et al., 2012</xref>). These experiments measure the exchange rate directly and are conducted at the low ligand concentrations, where the population of the fully bound EBH dimer with two peptides is much lower than that of a single peptide complex. This makes the indirect allosteric effect on the binding negligible and simplifies the binding model, thus providing direct information on the peptide interaction with the free protein. The large change of the <sup>15</sup>N chemical shifts for the residues in both the pre-formed part of the binding pocket (residues 220, 228, 247, 248, and 249) and the dynamic C-terminus that folds on the peptide binding (residues 250, 252, 255, and 255) allows independent measurement of the kinetic parameters for these two regions. As expected, we detected a strong CEST effect for all the residues with sufficiently large changes in the <sup>15</sup>N chemical shifts (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4A</xref>). Independent fitting of the CEST profiles for the individual residues (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4B</xref>) gave very similar dissociation rates for all the residues. We therefore obtained the overall exchange rates by simultaneous global fitting of all CEST profiles (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4B</xref>). The calculated dissociation rate of 143.6 ± 6.0 s<sup>–1</sup> was in excellent agreement with the lineshape TITAN analysis (<xref ref-type="table" rid="table1">Table 1</xref>). For the weaker EBH-ΔC/11MACF interaction, we did not detect any CEST effect, in agreement with the much faster dissociation rate of 1900 ± 54 s<sup>–1</sup> evaluated by the lineshape analysis (<xref ref-type="table" rid="table1">Table 1</xref>). For the stronger EBH/11MACF-VLL interaction, the intensity of the CEST effect was significantly lower than for EBH/11MACF at the same protein:peptide ratio, the exchange rates from the CEST were significantly higher than from the lineshape analysis, and protein:peptide ratio estimated by CEST was several times lower than used in the experiment. This indicates that the exchange rates are too slow for the accurate CEST analysis, in agreement with the low rate of 15.63 ± 0.12 s<sup>–1</sup> obtained by the lineshape fitting.</p></sec><sec id="s2-5"><title>Model of the target recognition by EBH</title><p>Based on the NMR structural and binding analysis, we proposed a two-step ‘dock-and-lock’ binding model (see above). We can now evaluate the binding parameters for each stage using the exchange parameters derived from the lineshape changes and CEST experiments. The C-terminal deletion of the EBH-ΔC fragment eliminates the ‘lock’ step and can be used to calculate the parameters for the docking. The fitting of the NMR lineshape changes to a two-state model gives K<sub>D</sub> of 26.6 ± 0.51 µM, close to the value of 41.5 ± 8.8 µM from the ITC measurements, and the dissociation rate of 1900 ± 54 s<sup>–1</sup> (<xref ref-type="table" rid="table1">Table 1</xref>). Since ITC is generally a more accurate method for the binding constant evaluation, we use the ITC value as the dissociation constant for the dock stage. The on-rate for the docking can then be evaluated as 45.8 ± 9.8 µM<sup>–1</sup> s<sup>–1</sup>, which is similar to the rates reported for diffusion-controlled binding (summarised in <xref ref-type="bibr" rid="bib27">Shammas et al., 2016</xref>). This agrees with the easy access to the open, partly formed binding pocket of EBH.</p><p>When analysing the lineshape changes for the full EB1c domain interactions with 11MACF and the mutated peptides, we did not detect separate signals from the intermediate ‘dock’ stage despite the large chemical shift difference between the free and the bound states and slow-exchange regime. In addition, we did not observe any exchange broadening for the EBH complex formed at the high access of the peptide, where the population of the free state is negligibly low. (Under these conditions, the complex is in the equilibrium between the ‘dock’ state where C-terminal region unfolded with the chemical shifts similar to the free state and the locked complex with the fully folded C-terminus.) The lack of signals from the ‘dock’ state and the absence of the exchange contribution from the exchange between the ‘dock’ and the ‘lock’ states suggests that the exchange between these states is very fast compared to the chemical shift differences, or the population of the intermediate ‘dock’ state is very low.</p><p>Under the conditions of the fast exchange between the two bound states (‘dock’ and ‘lock’), they can be represented by an average state, and the binding approximated by a two-state model (<xref ref-type="bibr" rid="bib8">Březina et al., 2022</xref>) with the overall dissociation constant <inline-formula><alternatives><mml:math id="inf4"><mml:msubsup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>`</mml:mi></mml:mrow></mml:msubsup></mml:math><tex-math id="inft4">\begin{document}$K_{D}^{'}$\end{document}</tex-math></alternatives></inline-formula> and rate <inline-formula><alternatives><mml:math id="inf5"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>`</mml:mi></mml:mrow></mml:msubsup></mml:math><tex-math id="inft5">\begin{document}$k_{off}^{'}$\end{document}</tex-math></alternatives></inline-formula> calculated as:<disp-formula id="equ1"><label>(1)</label><alternatives><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msubsup><mml:mi>K</mml:mi><mml:mi>D</mml:mi><mml:mo>′</mml:mo></mml:msubsup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mi>K</mml:mi><mml:mi>D</mml:mi><mml:mi>D</mml:mi></mml:msubsup></mml:mrow><mml:mspace width="thinmathspace"/><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>K</mml:mi><mml:mi>D</mml:mi><mml:mi>L</mml:mi></mml:msubsup></mml:mrow><mml:mrow><mml:msubsup><mml:mi>K</mml:mi><mml:mi>D</mml:mi><mml:mi>L</mml:mi></mml:msubsup><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t1">\begin{document}$$\displaystyle {K'_D} = {K^D_D}\,\frac{{K^L_D}}{{K^L_D + 1}}$$\end{document}</tex-math></alternatives></disp-formula><disp-formula id="equ2"><label>(2)</label><alternatives><mml:math id="m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:mspace width="thinmathspace"/><mml:mfrac><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t2">\begin{document}$$\displaystyle k'_{off} = k_{off}^{D} \, \frac{K_{D}^{L}}{K_{D}^{L} + 1}$$\end{document}</tex-math></alternatives></disp-formula></p><p>where <inline-formula><alternatives><mml:math id="inf6"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft6">\begin{document}$K_{D}^{D}$\end{document}</tex-math></alternatives></inline-formula> and <inline-formula><alternatives><mml:math id="inf7"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft7">\begin{document}$k_{off}^{D}$\end{document}</tex-math></alternatives></inline-formula> are the dissociation constant and rate of the dock step, respectively, and <inline-formula><alternatives><mml:math id="inf8"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft8">\begin{document}$K_{D}^{L}$\end{document}</tex-math></alternatives></inline-formula> is the dissociation constant of the lock step. These equations show that the overall dissociation constant <inline-formula><alternatives><mml:math id="inf9"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft9">\begin{document}$K_{D}^{'}$\end{document}</tex-math></alternatives></inline-formula> and rate <inline-formula><alternatives><mml:math id="inf10"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft10">\begin{document}$k_{off}^{'}$\end{document}</tex-math></alternatives></inline-formula> are scaled down proportionally to the fraction of the protein in the intermediate state relative to all bound population. Effectively, the ‘lock’ step depletes the population of the protein where ligand can dissociate, thus decreasing the overall dissociation constant and dissociation rate. If <inline-formula><alternatives><mml:math id="inf11"><mml:msubsup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>≪</mml:mo><mml:mn>1</mml:mn></mml:math><tex-math id="inft11">\begin{document}$K_{D}^{L}\ll 1$\end{document}</tex-math></alternatives></inline-formula>, corresponding to the case when most of the bound protein is in the final locked state, the overall constants decrease in proportion to the dissociation constant of the lock state.</p><p>The parameters of the ‘dock’ step can be estimated from the peptide interaction with EBH-ΔC that lacks the C-terminal and cannot transfer to the locked state (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). The dissociation constant of the ‘lock’ step can then be calculated from <xref ref-type="disp-formula" rid="equ1 equ2">Equations 1 and 2</xref>. Thus, for 11MACF <inline-formula><alternatives><mml:math id="inf12"><mml:msubsup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>41.5</mml:mn><mml:mo>±</mml:mo><mml:mn>8.8</mml:mn></mml:math><tex-math id="inft12">\begin{document}$K_{D}^{D}=41.5\pm 8.8$\end{document}</tex-math></alternatives></inline-formula> µM and <inline-formula><alternatives><mml:math id="inf13"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>1900</mml:mn><mml:mo>±</mml:mo><mml:mn>54</mml:mn></mml:math><tex-math id="inft13">\begin{document}$k_{off}^{D}=1900\pm 54$\end{document}</tex-math></alternatives></inline-formula> s<sup>–1</sup>, <inline-formula><alternatives><mml:math id="inf14"><mml:msubsup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>`</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>3.5</mml:mn><mml:mo>±</mml:mo><mml:mn>1.0</mml:mn></mml:math><tex-math id="inft14">\begin{document}$K_{D}^{'}=3.5\pm 1.0$\end{document}</tex-math></alternatives></inline-formula> µM and rate <inline-formula><alternatives><mml:math id="inf15"><mml:msubsup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>`</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>130.2</mml:mn><mml:mo>±</mml:mo><mml:mn>2.1</mml:mn></mml:math><tex-math id="inft15">\begin{document}$k_{off}^{'}=130.2\pm 2.1$\end{document}</tex-math></alternatives></inline-formula> s<sup>–1</sup>, (<xref ref-type="table" rid="table1">Table 1</xref>), giving <inline-formula><alternatives><mml:math id="inf16"><mml:msubsup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.08</mml:mn><mml:mo>-</mml:mo><mml:mn>0.07</mml:mn></mml:math><tex-math id="inft16">\begin{document}$K_{D}^{L}=0.08-0.07$\end{document}</tex-math></alternatives></inline-formula>. This corresponds to only ~8% of the bound population being in the intermediate dock state.</p><p>The low population of the ‘dock’ state could potentially still be sufficient to cause exchange line-broadening under fully bound conditions (large ligand excess) if the exchange rates for the lock process are sufficiently slow. The absence of the broadening suggests fast exchange on NMR timescale, with <inline-formula><alternatives><mml:math id="inf17"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>e</mml:mi><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>≫</mml:mo><mml:mn>2000</mml:mn><mml:mspace width="thinmathspace"/><mml:msup><mml:mi>s</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft17">\begin{document}$k_{ex}^{L}=k_{on}^{L}+k_{off}^{L}\gg 2000\, s^{-1}$\end{document}</tex-math></alternatives></inline-formula> (from the maximum differences in the chemical shifts between the free and the bound states). With <inline-formula><alternatives><mml:math id="inf18"><mml:msubsup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mi>q</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>≪</mml:mo><mml:mn>1</mml:mn></mml:math><tex-math id="inft18">\begin{document}$K_{eq}^{L}\ll 1$\end{document}</tex-math></alternatives></inline-formula>, the exchange is dominated by the on-rate, giving an estimate for <inline-formula><alternatives><mml:math id="inf19"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>≫</mml:mo><mml:mn>2000</mml:mn><mml:mspace width="thinmathspace"/><mml:msup><mml:mi>s</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft19">\begin{document}$k_{on}^{L}\gg 2000\, s^{-1}$\end{document}</tex-math></alternatives></inline-formula>.</p><p>When the population of the intermediate state is low, its contribution to the NMR signals becomes negligibly small, and the measured lineshape changes and CEST saturation transfer are only associated with the exchange between the free and the fully bound ‘lock’ forms. Under this condition, the overall on-rate of the two-step binding approximated with the two-site model is generally slower than the on-rate of the first dock step (see Appendix 1 for more information):<disp-formula id="equ3"><label>(3)</label><alternatives><mml:math id="m3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup><mml:mo>≤</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t3">\begin{document}$$\displaystyle k_{on}' \leq k_{on}^{D}$$\end{document}</tex-math></alternatives></disp-formula></p><p>with the rates becoming equal when the exchange in the second lock step is fast compared to the initial dock step (dock step is rate-limiting).</p><p>Using the parameters EBH-ΔC/11MACF binding as the approximation for the first ‘dock’ step and the EBH/11MACF binding for the overall parameters of the two-step model (<xref ref-type="table" rid="table1">Table 1</xref>), we estimate <inline-formula><alternatives><mml:math id="inf20"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>45.8</mml:mn><mml:mspace width="thinmathspace"/><mml:mo>±</mml:mo><mml:mspace width="thinmathspace"/><mml:mn>9.8</mml:mn></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft20">\begin{document}$k_{on}^{D}=45.8\, \pm \, 9.8$\end{document}</tex-math></alternatives></inline-formula> μM<sup>-1</sup> S<sup>-1</sup>and <inline-formula><alternatives><mml:math id="inf21"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>37</mml:mn><mml:mspace width="thinmathspace"/><mml:mo>±</mml:mo><mml:mspace width="thinmathspace"/><mml:mn>11</mml:mn></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft21">\begin{document}$k_{on}^{'}=37\, \pm \, 11$\end{document}</tex-math></alternatives></inline-formula> μM<sup>-1</sup> S<sup>-1</sup> (<xref ref-type="table" rid="table1">Table 1</xref>), in agreement with <xref ref-type="disp-formula" rid="equ3">Equation 3</xref>. The similarity of these ratios supports the fast exchange rate of the ‘lock’ step. The estimated kinetic parameters in the two-step model of the EBH/11MACF interaction are summarised in <xref ref-type="fig" rid="fig4">Figure 4D</xref>.</p><p>For the EBH-ΔC/11MACF-VLL, we observed a ~2-fold decrease in the dissociation constant, mostly associated with the increase in the on-rate to <inline-formula><alternatives><mml:math id="inf22"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mn>82</mml:mn><mml:mspace width="thinmathspace"/><mml:mo>±</mml:mo><mml:mspace width="thinmathspace"/><mml:mn>14</mml:mn></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft22">\begin{document}$82\, \pm \, 14$\end{document}</tex-math></alternatives></inline-formula> μM<sup>-1</sup> S<sup>-1</sup>. This could be explained by the additional hydrophobic interaction of the VLL region of the mutant peptide with the hydrophobic surface of the coiled-coil that is easily accessible and may help in steering the peptide docking. Interestingly, the on-rate of the EBH/11MACF-VLL interaction increases further to <inline-formula><alternatives><mml:math id="inf23"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mn>192</mml:mn><mml:mspace width="thinmathspace"/><mml:mo>±</mml:mo><mml:mspace width="thinmathspace"/><mml:mn>21</mml:mn></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft23">\begin{document}$192\, \pm \, 21$\end{document}</tex-math></alternatives></inline-formula> μM<sup>-1</sup> S<sup>-1</sup> on the addition of the EBH C-terminus, contrary to <xref ref-type="disp-formula" rid="equ3">Equation 3</xref>. This may reflect a more complex binding process. However, a more likely explanation is the difficulty of estimating accurately very slow rates from the lineshape analysis, as the lineshape becomes less sensitive to the variation in the exchange rate when the exchange is very slow. Assuming the fast exchange of the ‘lock’ step, we can calculate <inline-formula><alternatives><mml:math id="inf24"><mml:msubsup><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.0043</mml:mn></mml:math><tex-math id="inft24">\begin{document}$K_{D}^{L}=0.0043$\end{document}</tex-math></alternatives></inline-formula> from <xref ref-type="disp-formula" rid="equ1">Equation 1</xref>.</p><p>The decrease in <inline-formula><alternatives><mml:math id="inf25"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft25">\begin{document}$K_{D}^{L}$\end{document}</tex-math></alternatives></inline-formula> for 11MACF-VLL compared to 11MACF corresponds to a decrease in the population of the intermediate state from 0.08 to 0.0043. This is expected to cause a small increase in the difference in the chemical shift values between the free and the bound forms for the signals of the C-terminal residues of EBH. In agreement with this prediction, we observed a general systematic increase of the chemical shift differences for the residues at the C-terminus most affected by the peptide binding for 11MACF, 11MACF-VLL, and 11MACF-VLL (<xref ref-type="fig" rid="fig4">Figure 4A</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). This change supports the fast exchange of the C-terminus between the free and the bound state in the saturated complex, although non-linear shift changes between the complexes also indicate some conformational difference in the complex.</p><p>The dissociation constants measured for the different peptides (<xref ref-type="table" rid="table1">Table 1</xref>) allow us to define contributions from different regions into the free energy of the binding (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). These contributions can be assigned to the ‘dock’ and ‘lock’ stages. The short fragments 4MACF and 6MACF do not cause folding of the EBH C-terminus, leading only to a small decrease in ΔG on the increase of the peptide length from –11.312 ± 0.066 to –15.76 ± 0.34 kJ/mol. A much larger decrease in free energy to –31.20 ± 0.81 kJ/mol is observed for the full 11MACF that induces C-terminal folding. Some of this –19.9 kJ/mol total decrease is associated with the two additional N-terminal residues (~–6 kJ/mol, difference between 9MACF and 11MACF peptides), although the majority of the ΔG decrease (~–14 kJ/mol) is caused by the C-terminal extension. This demonstrates that approximately half of the free energy change on the binding is defined by the recognition of the SxIP motif, and the rest by the much less specific binding of the variable sequence that immediately follows SxIP, with a smaller contribution from the variable N-terminal region. The high contribution from SxIP makes the dock stage very sensitive to single-residue mutations in the recognition part of the peptide.</p><p>The folding of the C-terminus reduces ΔG by ~–6.6 kJ/mol, released in the ‘lock stage’ of the interaction (the difference between EBH/11MACF and EBH-ΔC/11MACF binding energies), bringing the overall <inline-formula><alternatives><mml:math id="inf26"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft26">\begin{document}$K_{D}^{'}$\end{document}</tex-math></alternatives></inline-formula> from high- to low-micromolar range. The TPQ sequence of 11MACF is not ideal for the interaction with the hydrophobic EBH C-terminus. Replacing this with a hydrophobic VLL sequence improves the match between the peptide and the EB1 C-terminus and reduces free energy from the interaction between the peptide and EB1 C-terminus by an additional ~–9.3 kJ/mol. Notably, the dependence of the binding constants of interactions of EBH-ΔC on peptide length and composition shows that a most significant contribution to the binding comes from the interaction between post-SxIP residues and the coiled-coil region of EB1c domain, although the pre-SxIP residues also have a significant effect.</p><p>Further reduction of the free energy of ~–4.1 kJ/mol is possible by adding positively charged residues to the peptide C-terminus that interact non-specifically with the negatively charged surface of EBH. Strong contribution from the electrostatic interaction is supported by a large increase in the dissociation constant on the increase of the salt concentration from 50 to 150 mM for the EBH/11MACF-VLLRK interaction from 16 ± 3 nM to 198 ± 12 nM (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>).</p><p>The variation of the sequence in the post-SxIP region observed in the EBH ligands (<xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4C</xref>) is expected to affect strongly the affinity of the SxIP ligands, with more hydrophobic sequences binding stronger. To test this, we measured the affinity of the SxIP peptide from CK5P2 (KKSRLPRILIKRSR) that has a C-terminal sequence that is similar to the 13MACF-VLLRK mutant. As predicted, the 13CK5P2 had K<sub>D</sub> = 21 ± 2.2 nM that is very close to that of the mutant.</p><p>Overall, the change in the free energy on the complex formation consists of three similar contributions: SxIP binding to the partially formed binding pocket, non-specific interactions between the post-SxIP region and the folded part of EBH and folding-induced interaction between the unstructured EBH C-terminus and post-SxIP region of the peptide. Additional, smaller, contribution comes from the N-terminal residues immediately preceding SxIP.</p></sec><sec id="s2-6"><title>High affinity peptides localise into comet-like structures in cells</title><p>Through the rational optimisations of the peptide sequences, we generated SxIP peptides with the enhanced affinity to EB1. To relate their affinity to the EB1-dependent recruitment to the plus ends of MTs, we inserted them into an mTFP containing mammalian vector and followed their ability to localise into mCherry-EB1 comets in HeLa cells. For the WT peptide (K<sub>D</sub> = 3.5 ± 1.0 µM), we observed a ubiquitous cytosolic localisation with little to no peptide localised into comets (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), similar to that of the GFP control. Close inspection of images and movies at high contrast revealed a small number of comets enriched in the peptide that were too faint for the quantitative analysis, comparable, although lower, to the reported previously (<xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>). A measurable localisation to comets could be detected with the MACF-VLLRK peptide (K<sub>D</sub> = 16 nM). However, the ratio of peptide to EB1 comets was extremely low at around 0.02 (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), showing that only a small number of comets contained detectable amounts of the peptide. This ratio dramatically increased to ~0.8 with the dimeric MACF-LZ-VLLRK peptide, showing that only a dimer localised to almost every plus end comet we traced. EB1 comet number remained the same with all peptide transfections (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). These experiments suggest that the enhanced affinity increases the localisation of ligands to MTs, but even nanomolar affinity is still insufficient for the recruitment of the monomeric ligand.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>High-affinity peptides form comet-like structures that colocalise with EB1 comets.</title><p>(<bold>A</bold>) Live images of HeLa cells transiently transfected with SxIP peptide constructs and EB1 plasmid. Images represent averaging three frames at 1 s intervals. Insets represent zoomed-in regions of the cell to depict SxIP peptides at EB1 comets. Scale bar: 5 µM. (<bold>B</bold>) Ratio of SxIP comets to EB1 comets present in a cell. (<bold>C</bold>) EB1 comet number per cell. Lines represent the mean with error bars representing the standard deviation. Changes in comet number with each peptide were not significant when t-test was used with the EB1 construct-only control (EB1). All experiments were performed to an N=3.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Values of the ratios of SxIP to EB1 in the comets and comet numbers for <xref ref-type="fig" rid="fig5">Figure 5B and C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-98063-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-98063-fig5-v1.tif"/></fig><p>Notably, the number of comets we detected with our monomeric constructs was significantly smaller than reported by <xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>. Considering a very strong effect of dimerisation on the localisation of the SxIP peptides, this is likely to be due to the ability of EGFP used in their study to form weak dimers that is absent in our mTFP fluorescent tag.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The interaction of EB1 with the SxIP motif-containing proteins is fundamental to the assembly of signalling complexes at the plus ends of MTs. These complexes regulate the assembly and stability of MTs themselves, guide MT growth, and link MTs to other cellular processes, such as cell division or assembly of adhesion complexes (<xref ref-type="bibr" rid="bib2">Akhmanova and Steinmetz, 2008</xref>; <xref ref-type="bibr" rid="bib17">Howard and Hyman, 2003</xref>). In this study, we demonstrated that while the SxIP motif is the only conserved feature of the SxIP-containing proteins, it alone is insufficient for the high-affinity interaction. By comparing the interaction of the EBH domain of EB1 with a range of SxIP-containing peptides, we identified the critical role of the post-SxIP region in the complex formation. These residues induce folding of the EBH unstructured C-terminus following the initial docking via the SxIP motif, which increases affinity by several orders of magnitude. Thus, the overall binding of the SxIP-containing ligands to EBH can be described as a two-step dock-and-lock process, with the initial docking through SxIP motif providing the specificity of the interaction, and the subsequent folding of the EBH C-terminus defining the full binding affinity (<xref ref-type="fig" rid="fig4">Figure 4D and E</xref>). We evaluated the kinetic parameters of the binding and the contributions from different regions into the binding energy and used the model to increase the affinity of the SxIP peptide ~100-fold through mutations of the post-SxIP region. The mutated peptide showed enhanced dynamic recruitment to the plus ends of MTs in cells, supporting the functional role of the post-SxIP region. We identified previously uncharacterised SxIP-containing EBH ligand CK5P2 (KKSRLPRILIKRSR) with the post-SxIP region that is similar to our high-affinity mutant 13MACF-VLLRK and demonstrated that it has similarly high-affinity K<sub>D</sub> of 21 ± 2.2 nM. Overall, our results agree and extend the reported analysis of the substitutions of the individual residues in the SxIP ligands (<xref ref-type="bibr" rid="bib9">Buey et al., 2012</xref>) and provide a dynamic model for the target recognition by EB1.</p><p>Our dock-and-lock model is a variant of the induced fit that is a dominant binding mechanism of IDPs (<xref ref-type="bibr" rid="bib31">Sugase et al., 2007</xref>; <xref ref-type="bibr" rid="bib36">Wright and Dyson, 2009</xref>; <xref ref-type="bibr" rid="bib24">Mollica et al., 2016</xref>). We used a separate name for our model to highlight the clear structural definitions of each step of the binding and the lack of the internal motions in the complex. Our previously reported structure (<xref ref-type="bibr" rid="bib4">Almeida et al., 2017</xref>) and the relaxation analysis reported here (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) demonstrate that in the absence of the ligand, the EBH domain has only partially formed SxIP binding site and a dynamic C-terminus. Because of this, the ligands initially interact with only the folded part of EBH, and the folding is induced after the binding, which mechanistically justifies the two-step model. The combination of the NMR data shows that folding of the C-terminus happens too fast, making its direct detection and evaluation impossible. As a result, the overall binding process can be approximated by a simple two-step binding. However, this model does not fit with the mechanistic description of the binding process from the structural information and does not provide insights into the binding mechanism and contribution from different regions of EBH and the SxIP ligand. We, therefore, adopted a structurally supported two-step binding model for our analysis and used EBH and ligand truncations to evaluate the kinetic parameters of each step and contributions from different regions into the binding.</p><p>The SxIP motif itself has an extremely low affinity to EBH as it fails to induce the formation of the full binding pocket through folding the EBH C-terminus. This folding requires post-SxIP residues that immediately follow the SxIP motif. The folding is driven by the hydrophobic interaction of the FVIP region in the dynamic EBH C-terminus that folds on top of the post-SxIP region and locks it in the position through the stacking of two Phe aromatic rings (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). These interactions completely immobilise the EBH C-terminus and the peptide ligand, making the completed binding pocket as rigid as the rest of the EBH coiled-coil structure (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><p>This type of binding resembles the interaction of HIV-1 protease with group-specific oncogene (Gag), where the protease has dynamic flaps that fold over the bound substrate and trap it in the catalytic site, thus facilitating the catalysis (<xref ref-type="bibr" rid="bib13">Deshmukh et al., 2017</xref>). Similar loop folding has also been observed in other enzymes, such as some classes of sulfatransferases and lipases, where the closed loops shield the substrates from the bulk solvent and prevent non-productive hydrolysis (<xref ref-type="bibr" rid="bib11">Cook et al., 2013</xref>; <xref ref-type="bibr" rid="bib19">Khan et al., 2017</xref>). However, this is rather unusual in the adaptor proteins similar to EB1 function. In the majority of the reported cases, the folding is limited to the initially unstructured ligand (<xref ref-type="bibr" rid="bib25">Morris et al., 2021</xref>). Part of the ligand often remains dynamic in the complex, forming a set of fuzzy interactions with the folded partner (<xref ref-type="bibr" rid="bib31">Sugase et al., 2007</xref>).</p><p>The dock-and-lock mechanism of the EBH binding has a number of functional benefits. The open, partly formed binding pocket is easily accessible, leading to the fast on-rate. The initial, partly formed, binding pocket is very small, primarily fitting the Ile side chain. This makes the pocket highly suitable for the recognition of the short SxIP motif. Despite the small size, the pocket has a very distinct shape, leading to a very specific recognition. However, because of the small size, the binding energy is low, resulting in the high off-rate. This explains the high specificity, but low affinity of the SxIP binding.</p><p>The additional residues that follow the SxIP motif contribute in two different ways. First, they enhance the affinity through the interaction with the folded EB1c coiled-coil, with the increase of K<sub>D</sub> from 2 mM for 6MACF to 41 µM for the 11MACF interaction with EBH-ΔC (<xref ref-type="table" rid="table1">Table 1</xref>). The fast off-rate of 1900 ± 54 s<sup>–1</sup> determined for the 11MACF/EBH-ΔC interaction from the chemical shift changes in the <sup>1</sup>H,<sup>15</sup>N-HSQC spectra corresponds to a very high on-rate of 45.8 ± 9.8 µM<sup>–1</sup> s<sup>–1</sup> calculated from the K<sub>D</sub> value. This is similar to the reported diffusion-controlled rates enhanced by the electrostatic interactions (<xref ref-type="bibr" rid="bib31">Sugase et al., 2007</xref>; <xref ref-type="bibr" rid="bib26">Shammas et al., 2013</xref>), which agrees with the open binding pocket and contributions of the C-terminal positive charges of the peptide identified with the mutations and strong dependence of the affinity on the salt concentration (<xref ref-type="bibr" rid="bib9">Buey et al., 2012</xref>). Limited chemical shift perturbations outside of the SxIP pocket for the 11MACF/EBH-ΔC interaction suggest that in the absence of the C-terminus, the interactions of the post-SxIP residues with the folded coiled-coil region are transient and have more effect on the on- than the off-rate.</p><p>The second effect of the post-SxIP residues is to induce the folding of the EBH C-terminus, which locks the peptide into the fully folded state. While not available from the direct measurements, the rate of this step can be evaluated from the rates of the dock step (above) and the overall rate for the complex formation using the two-step model. Both chemical shift analysis and CEST measurement give consistent values for the overall off-rate of ~130 s<sup>–1</sup> for the 11MACF/EBH interaction. This corresponds to ~15-fold decrease from the rate 1900 ± 54 s<sup>–1</sup> of the dock step, which is similar to the differences in the overall K<sub>D</sub> values for the 11MACF/EBH-ΔC (only dock step) and 11MACF/EBH (both dock and lock steps). The proportional decrease corresponds to the fast exchange condition for the lock step (<xref ref-type="bibr" rid="bib8">Březina et al., 2022</xref>), with forward rate &gt;&gt;2000 s<sup>–1</sup>, estimated from the chemical shift differences. This rate is much higher than the dissociation rate of the dock step. As a result, the binding is highly productive, with practically all encounter complexes proceeding to the fully bound state.</p><p>Overall, the binding mechanism of EBH maximises the on-rate through the open binding pocket optimised for the short SxIP domain recognition, making this motif the only feature required for the target recognition. Insufficient binding affinity of the small SxIP-recognition pocket is strongly enhanced by the folding induced by the post-SxIP region. The main requirement for this region is to support the hydrophobic interactions with the EBH C-terminus. These interactions are much less specific as the dynamic C-terminus can adjust and accommodate the changes. This allows for significant sequence variation and explains the high conservation of the SxIP motif and lack of the conservation in the post-SxIP region (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). Notably, many IDR ligands have a small number of key hydrophobic residues that are critical for the formation of the encounter complex (<xref ref-type="bibr" rid="bib31">Sugase et al., 2007</xref>). It is not clear yet whether these residues define small recognition motifs for all the IDR ligands, or only some IDR, such as SxIP ligands, have well-defined small recognition motifs.</p><p>Based on the understanding of the post-SxIP region contribution to the affinity, we designed an MACF mutant 13MACF-VLLRK with a highly increased affinity from 3.5 ± 1.0 µM to 16 ± 3 nM. In this design, we increased the hydrophobicity of the immediate post-SxIP region that interacts with the EBH C-terminus and introduced additional charges at the peptide C-terminus to enhance the electrostatic steering effect. These substitutions agree with the reported previously systematic single-residue replacement analysis (<xref ref-type="bibr" rid="bib9">Buey et al., 2012</xref>), extending it to the multi-residue substitutions. We found that some of the SxIP ligands contain hydrophobic post-SxIP residues, similar to our high-affinity mutant (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>), and validate high-affinity interaction of one of them, CK5P2, with K<sub>D</sub> of 21 ± 2.2 nM (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig4s4">Figure 4—figure supplement 4C</xref>). This demonstrates the scope of the affinity modulation through the variation in the post-SxIP regions of different EBH ligands that can be identified from the sequence comparison.</p><p>Endogenous EB1 forms dynamic condensates via phase separation that track plus ends of MTs in comet-like structures (<xref ref-type="bibr" rid="bib30">Song et al., 2023</xref>). These structures recruit many of the SxIP-containing +TIPs proteins such as MACF and APC (<xref ref-type="bibr" rid="bib20">Kita et al., 2006</xref>; <xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>) and regulate MT polymerisation, catastrophe, and rescue (<xref ref-type="bibr" rid="bib33">Vaughan, 2005</xref>). The SxIP +TIP proteins effectively localise to EB1 comets (<xref ref-type="bibr" rid="bib3">Akhmanova and Steinmetz, 2015</xref>) and condensates (<xref ref-type="bibr" rid="bib30">Song et al., 2023</xref>), and enhance condensate formation to a different degree (<xref ref-type="bibr" rid="bib30">Song et al., 2023</xref>). We found that the comet localisation depends on the SxIP-peptide affinity, but even the mutant peptide with the nanomolar affinity does not localise effectively (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Only when the peptide was dimerised through the leucine-zipper motif did the number of the SxIP comets become similar to the number of EB1 comets per cell (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). This shows that the recruitment of the SxIP ligands requires multi-valent interactions that are characteristic of the condensates (<xref ref-type="bibr" rid="bib6">Boeynaems et al., 2018</xref>; <xref ref-type="bibr" rid="bib38">Zumbro and Alexander-Katz, 2021</xref>; <xref ref-type="bibr" rid="bib23">Mohanty et al., 2022</xref>) and is partly driven by the condensation. Notably, most of the SxIP proteins contain additional interaction sites with other +TIP proteins, and some of them have multiple SxIP motifs (<xref ref-type="bibr" rid="bib21">Kumar and Wittmann, 2012</xref>; <xref ref-type="bibr" rid="bib3">Akhmanova and Steinmetz, 2015</xref>). Therefore, effective targeting of the SxIP and other interactions in the +TIP MT networks may require high-affinity multi-valent inhibitors, which should be considered in the future drug development.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (human)</td><td align="left" valign="bottom">pOPINS, EKAR2G_design1_mTFP_wt_Venus_wt</td><td align="left" valign="bottom">UniProt</td><td align="left" valign="bottom">Q15691, MAPRE1</td><td align="left" valign="bottom">EBH domain of EB1, expression construct</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">BL21(DE3)</td><td align="left" valign="bottom">NEB</td><td align="left" valign="bottom">C2530H</td><td align="left" valign="bottom">Chemically competent cells</td></tr><tr><td align="left" valign="bottom">Cell line (human)</td><td align="left" valign="bottom">HeLa</td><td align="left" valign="bottom">AATC</td><td align="left" valign="bottom">PCS-201–012, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:CVCL_0030">CVCL_0030</ext-link></td><td align="left" valign="bottom">Mycoplasma negative</td></tr><tr><td align="left" valign="bottom">Transfected construct (human)</td><td align="left" valign="bottom">EKAR2G_design1_mTFP_wt_Venus_wt</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Plasmid #39813, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_39813">Addgene_39813</ext-link></td><td align="left" valign="bottom">FRET vector</td></tr><tr><td align="left" valign="bottom">Transfected construct (human: MAPRE1)</td><td align="left" valign="bottom">mCherry-EB1-8</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Plasmid #55035, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_55035">Addgene_55035</ext-link></td><td align="left" valign="bottom">C-terminal mCherry tag</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pOPINS (plasmid)</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Plasmid #41115, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_41115">Addgene_41115</ext-link></td><td align="left" valign="bottom">SUMO-tag expression vector</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">EBH fragment</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Protein preparation is described in Materials and methods. Plasmid for the expression available from the corresponding author.</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">SxIP peptides</td><td align="left" valign="bottom">ChinaPeptides (Shanghai)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Set of synthetic peptides</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">In-Fusion HD Cloning</td><td align="left" valign="bottom">Clontech</td><td align="left" valign="bottom">Clontech:639647, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_004423">SCR_004423</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">CBR-5884</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">SML1656, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_008988">SCR_008988</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Lipofectamine 3000</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">#L3000015</td><td align="left" valign="bottom">Transfection reagent</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">SPSS</td><td align="left" valign="bottom">SPSS</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002865">SCR_002865</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Microcal PEAQ-ITC Software, v. 1.41</td><td align="left" valign="bottom">Malvern</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_023795">SCR_023795</ext-link></td><td align="left" valign="bottom">ITC data analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">TopSpin 4.3</td><td align="left" valign="bottom">Bruker</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_014227">SCR_014227</ext-link></td><td align="left" valign="bottom">NMR data processing</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">CCPNmr Analysis v2.4</td><td align="left" valign="bottom">CCPN</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_016984">SCR_016984</ext-link></td><td align="left" valign="bottom">NMR data analysis software</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Relax 4.1.1</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18085411/">18085411</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">NMR relaxation analysis</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ChemEx 2018.10.2</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/gbouvignies/chemex">https://github.com/gbouvignies/chemex</ext-link>; <xref ref-type="bibr" rid="bib7">Bouvignies, 2025</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">CEST data analysis</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DAPI stain</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">D1306</td><td align="left" valign="bottom">Commercial nuclear stain<break/>(1 µg/mL)</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Peptides and protein preparation</title><p>Human EB1 (Uniprot code Q15691), residues 191–260 and 191–252, was purified as previously described (<xref ref-type="bibr" rid="bib4">Almeida et al., 2017</xref>).</p><p>Synthetic MACF peptides with purity &gt;95% were purchased from ChinaPeptides (Shanghai). Peptide amino acid sequences are: 4MACF (SKIP), 6MACF (SKIPTP), 9MACF (SKIPTPQRK), 11MACF (KPSKIPTPQRK), 11MACF-VLL (KPSTAKSKIPVLL), 11MACF-LLL (KPSTAKSKIPLLL), 11MACF-VLLRK (KPSTAKSKIPVLLRK), and 13CK5P2 (KKSRLPRILIKRSR). Peptides were dissolved with Milli-Q ultrapure water to make 10–20 mM stock solutions; pH was adjusted to 7 with NaOH.</p></sec><sec id="s4-2"><title>NMR spectroscopy</title><p>NMR spectra were collected on Bruker Avance III 600 and Neo 800 MHz spectrometers equipped with CryoProbes. Spectra were processed with TopSpin 4.3 (Bruker) and analysed using CCPNmr Analysis v2.4 (<xref ref-type="bibr" rid="bib34">Vranken et al., 2005</xref>). Experiments were performed at 298 K in 20 mM phosphate pH 6.5, 50 mM NaCl, 0.5 mM TCEP, 0.02% (wt/vol) NaN<sub>3</sub>.</p><p>To achieve full saturation of the complex, data for structure calculations was collected with a slight excess of ligand and 10:11 EB1/11MACF ratio. The backbone resonances were assigned using triple resonance experiments (HNCO, HN(CA)CO, HNCA, HNCACB, and CBCACONH) measured for <sup>13</sup>C-<sup>15</sup>N labelled EB1 using standard assignment protocols in CCPN analysis.</p><p>Side chain resonance assignments were obtained using HBHA(CO)NH, H(C)CH-TOCSY, and (H)CCH-TOCSY experiments. Aromatic side chains were assigned using 2D-NOESY and <sup>1</sup>H-<sup>13</sup>C-resolved-NOESY-HSQC. The resonances of the ligands were assigned using <sup>13</sup>C,<sup>15</sup>N-filtered 2D TOCSY and NOESY experiments. The structures were calculated using ARIA 2.2 integrated with CCPNmr analysis (<xref ref-type="bibr" rid="bib34">Vranken et al., 2005</xref>), as fully described previously (<xref ref-type="bibr" rid="bib4">Almeida et al., 2017</xref>). Statistics of the structure determination are presented in <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>.</p><p>Standard Bruker <sup>1</sup>H,<sup>15</sup>N-HSQC sequence hsqcfpf3gpphwg with soft-pulse watergate water suppression and flip-back pulse was used for the NMR lineshape analysis. A series of <sup>1</sup>H,<sup>15</sup>N-HSQC spectra were collected for the <sup>15</sup>N-labelled EBH domain with variable concentrations of the peptide. The range of the peptide concentrations has been selected to ensure maximum saturation at the highest concentration and even distribution of the saturation states throughout the titration. The concentrations used are listed in the supplementary material (see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1</xref> and <xref ref-type="fig" rid="fig1s3">3</xref>). The titration HSQC data were analysed in TITAN software (v1.6) (<xref ref-type="bibr" rid="bib35">Waudby et al., 2016</xref>). For the EBH-ΔC/11MACF, the 1:1 binding model was used because chemical shift changes were linear and no allosteric effect from binding to the two different binding sites in the dimer was detected. For EBH-/11MACF and EBH-ΔC/11MACF-VLL, we observed non-linear changes of chemical shifts and multiple HSQC peaks corresponding to the non-symmetrical complex where only one binding site in the dimer is occupied. To account for this, we used the dimer binding model implemented in TITAN. For each residue with a significant chemical shift perturbation that can be followed throughout the titration, lineshapes for the free state and the final titration point were initially fitted to evaluate the parameters of the free state and the complex. Then, the titration series was fitted separately for each residue to obtain residue-specific exchange parameters. Finally, the lineshapes were fitted for all selected residues simultaneously to evaluate the global exchange rate.</p><p>The <sup>15</sup>N CEST experiments (<xref ref-type="bibr" rid="bib32">Vallurupalli et al., 2012</xref>) were conducted for samples containing 0.75 mM <sup>15</sup>N EB1 and 2.5% (molar) of the MACF peptide at a <sup>1</sup>H frequency of 800 MHz and 298 K. CEST profiles were measured at <sup>15</sup>N B1 field strength of 12.5, 25, and 50 Hz applied during a constant period of 400 ms using the standard Bruker pulse sequence. For the residues with detected CEST NMR exchange, data at all B1 values were fitted separately for each residue and simultaneously for all the residues using the ChemEx software (<ext-link ext-link-type="uri" xlink:href="https://github.com/gbouvignies/chemex">https://github.com/gbouvignies/chemex</ext-link>) as described previously (<xref ref-type="bibr" rid="bib32">Vallurupalli et al., 2012</xref>).</p><p>The <sup>15</sup>N relaxation rates R<sub>1</sub>, R<sub>2</sub>, and {<sup>1</sup>H}-<sup>15</sup>N heteronuclear Overhauser effects (nOes) were measured at <sup>1</sup>H frequencies of 600 and 800 MHz and 298 K using HSQC-based pulse sequences using standard Bruker pulse sequences. EBH concentration on the samples was 0.5 mM; 3 mM MACF peptide was used to ensure full saturation of the complex. To obtain the dynamic parameters, the data were analysed in the Relax 4.1.3 software (<xref ref-type="bibr" rid="bib12">d’Auvergne and Gooley, 2008</xref>) using standard protocols.</p></sec><sec id="s4-3"><title>Isothermal titration calorimetry</title><p>ITC experiments were performed using the MicroCal ITC200 and Malvern MicroCal Automated PEAQ-ITC instruments. Both protein and peptides were dialysed into 50 mM phosphate (pH 6.5), 50 mM NaCl, 0.5 mM TCEP, and 0.02% NaN<sub>3</sub> before use. To test the salt dependence of K<sub>D</sub>, the salt concentration in the buffer was increased to 150 mM NaCl. The sample cell and syringe were filled with 20–40 µM EB1 EBH domain and 200–600 µM MACF peptide, respectively. 1.5 µL of MACF peptides were injected into the sample cell for a total of 25 injections. All experiments were performed in triplicate and at 25°C. The data were integrated and fitted into the single-site binding model using the Malvern PEAQ-ITC Control software v1.41. The experiments were performed in triplicates to evaluate standard deviation. Data were analysed using Microcal PEAQ-ITC software v1.41.</p></sec><sec id="s4-4"><title>Cell culture</title><p>HeLa cells were cultured in Dulbecco’s Modified Eagle Serum substituted with 10% fetal bovine serum and 1% penicillin/streptavidin. Cells were maintained at 37°C and 5% CO<sub>2</sub>. HeLa cells were obtained from the ATCC (CCL-2), authenticated by provider using STR profiling. Negative for mycoplasma.</p></sec><sec id="s4-5"><title>MACF peptide constructs and transfection</title><p>Peptide sequences WT (GSRPSTAKPSKIPTPQRK), VLLRK (GSRPSTAKPSKIPVLLRKRK), and dimeric LZ-VLLRK peptide containing GCN4p1 leucine zipper (RMKQLEDKVEELLSKNYHLENEVARLKKLVGERGSRPSTAKPSKIPVLLRK) were inserted into a EKAR2G_design1_mTFP_wt_Venus_wt vector courtesy of Oliver Pertz (Addgene plasmid #39813; <ext-link ext-link-type="uri" xlink:href="http://n2t.net/addgene:39813">http://n2t.net/addgene:39813</ext-link>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_39813">Addgene_39813</ext-link>). The peptides were inserted at the mTFP C-terminus between the BspEI and EcoRV restriction sites of the vector. The design followed <xref ref-type="bibr" rid="bib16">Honnappa et al., 2009</xref>, to allow for the direct comparison with the published results. The peptides were separated from mTFP by the GS sequence of the vector and contained another GS at the N-terminus, creating a highly flexible GSGS linker that minimises potential effect of mTFP on the interaction.</p><p>Peptide constructs were co-transfected into HeLa cells with an mCherry-EB1 construct using Lipofectamine 3000 reagent following the manufacturer’s instructions (Invitrogen #L3000015). mCherry-EB1-8 was a gift from Michael Davidson (Addgene plasmid #55035, <ext-link ext-link-type="uri" xlink:href="http://n2t.net/addgene:55035">http://n2t.net/addgene:55035</ext-link>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:Addgene_55035">Addgene_55035</ext-link>). Imaging was performed 24 hr after transfection.</p></sec><sec id="s4-6"><title>Live-cell imaging</title><p>Live-cell images were obtained using the Marianas spinning disk confocal microscope system (Intelligent Imaging Innovations, Inc) and Slidebook2022 (reference) capture software. Total internal reflection microscopy (TIRFM) was employed using 100×1.49 NA lens, 488 (FF01-525/30-25) and 561 (FF01-617/73-25) lasers with images captured using a Hamamatsu C11440 camera.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Investigation, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Investigation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Supervision, Writing – original draft</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Formal analysis, Supervision, Methodology, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-98063-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The coordinates for the solution structure of EBH/MACF complex are deposited in the PDB, accession code 7OLG (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2210/pdb7olg/pdb">https://doi.org/10.2210/pdb7olg/pdb</ext-link>). The chemical shifts are deposited in the BMRB, accession code 34629. The relaxation data are deposited to BMRB, access codes 53187 (free EBH) and 53188 (EBH/11MACF complex).</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>TB</given-names></name><name><surname>Barsukov</surname><given-names>IL</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>EB1 bound to MACF peptide</data-title><source>Worldwide Protein Data Bank</source><pub-id pub-id-type="doi">10.2210/pdb7olg/pdb</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>TB</given-names></name><name><surname>Barsukov</surname><given-names>IL</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>EB1 bound to MACF peptide</data-title><source>BMRB</source><pub-id pub-id-type="accession" xlink:href="https://bmrb.io/data_library/summary/index.php?bmrbId=34629">34629</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset3"><person-group person-group-type="author"><name><surname>Barsukov</surname><given-names>I</given-names></name><name><surname>Hargreaves</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>EB1 EBH(191-260) relaxation data</data-title><source>BMRB</source><pub-id pub-id-type="accession" xlink:href="https://bmrb.io/data_library/summary/index.php?bmrbId=53187">53187</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset4"><person-group person-group-type="author"><name><surname>Barsukov</surname><given-names>I</given-names></name><name><surname>Hargreaves</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>EB1 EBH(191-260) bound to MACF peptide, relaxation data</data-title><source>BMRB</source><pub-id pub-id-type="accession" xlink:href="https://bmrb.io/data_library/summary/index.php?bmrbId=53188">53188</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>TA was funded by Liverpool University PhD studentship. EH was funded by BBSRC DTP NLD studentship. The NMR spectra were measured at the LIV-SRF High-Field NMR Facility, University of Liverpool. The images were collected at the LIV-SRF Centre for Cell Imaging (CCI) Facility, University of Liverpool.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abiatari</surname><given-names>I</given-names></name><name><surname>Gillen</surname><given-names>S</given-names></name><name><surname>DeOliveira</surname><given-names>T</given-names></name><name><surname>Klose</surname><given-names>T</given-names></name><name><surname>Bo</surname><given-names>K</given-names></name><name><surname>Giese</surname><given-names>NA</given-names></name><name><surname>Friess</surname><given-names>H</given-names></name><name><surname>Kleeff</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The microtubule-associated protein MAPRE2 is involved in perineural invasion of pancreatic cancer cells</article-title><source>International Journal of Oncology</source><volume>35</volume><fpage>1111</fpage><lpage>1116</lpage><pub-id pub-id-type="doi">10.3892/ijo_00000426</pub-id><pub-id pub-id-type="pmid">19787265</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhmanova</surname><given-names>A</given-names></name><name><surname>Steinmetz</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Tracking the ends: a dynamic protein network controls the fate of microtubule tips</article-title><source>Nat Rev Mol Cell Biol</source><volume>9</volume><fpage>309</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1038/nrm2369</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhmanova</surname><given-names>A</given-names></name><name><surname>Steinmetz</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Control of microtubule organization and dynamics: two ends in the limelight</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>16</volume><fpage>711</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1038/nrm4084</pub-id><pub-id pub-id-type="pmid">26562752</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>TB</given-names></name><name><surname>Carnell</surname><given-names>AJ</given-names></name><name><surname>Barsukov</surname><given-names>IL</given-names></name><name><surname>Berry</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Targeting SxIP-EB1 interaction: An integrated approach to the discovery of small molecule modulators of dynamic binding sites</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>15533</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-15502-6</pub-id><pub-id pub-id-type="pmid">29138501</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aseervatham</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cytoskeletal remodeling in Cancer</article-title><source>Biology</source><volume>9</volume><elocation-id>385</elocation-id><pub-id pub-id-type="doi">10.3390/biology9110385</pub-id><pub-id pub-id-type="pmid">33171868</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeynaems</surname><given-names>S</given-names></name><name><surname>Alberti</surname><given-names>S</given-names></name><name><surname>Fawzi</surname><given-names>NL</given-names></name><name><surname>Mittag</surname><given-names>T</given-names></name><name><surname>Polymenidou</surname><given-names>M</given-names></name><name><surname>Rousseau</surname><given-names>F</given-names></name><name><surname>Schymkowitz</surname><given-names>J</given-names></name><name><surname>Shorter</surname><given-names>J</given-names></name><name><surname>Wolozin</surname><given-names>B</given-names></name><name><surname>Van Den Bosch</surname><given-names>L</given-names></name><name><surname>Tompa</surname><given-names>P</given-names></name><name><surname>Fuxreiter</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Protein phase separation: a new phase in cell biology</article-title><source>Trends in Cell Biology</source><volume>28</volume><fpage>420</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2018.02.004</pub-id><pub-id pub-id-type="pmid">29602697</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Bouvignies</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>ChemEx</data-title><version designator="2eb9aa8">2eb9aa8</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/gbouvignies/chemex">https://github.com/gbouvignies/chemex</ext-link></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Březina</surname><given-names>V</given-names></name><name><surname>Hanyková</surname><given-names>L</given-names></name><name><surname>Velychkivska</surname><given-names>N</given-names></name><name><surname>Hill</surname><given-names>JP</given-names></name><name><surname>Labuta</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>NMR lineshape analysis using analytical solutions of multi-state chemical exchange with applications to kinetics of host-guest systems</article-title><source>Scientific Reports</source><volume>12</volume><elocation-id>17369</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-20136-4</pub-id><pub-id pub-id-type="pmid">36253475</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buey</surname><given-names>RM</given-names></name><name><surname>Sen</surname><given-names>I</given-names></name><name><surname>Kortt</surname><given-names>O</given-names></name><name><surname>Mohan</surname><given-names>R</given-names></name><name><surname>Gfeller</surname><given-names>D</given-names></name><name><surname>Veprintsev</surname><given-names>D</given-names></name><name><surname>Kretzschmar</surname><given-names>I</given-names></name><name><surname>Scheuermann</surname><given-names>J</given-names></name><name><surname>Neri</surname><given-names>D</given-names></name><name><surname>Zoete</surname><given-names>V</given-names></name><name><surname>Michielin</surname><given-names>O</given-names></name><name><surname>de Pereda</surname><given-names>JM</given-names></name><name><surname>Akhmanova</surname><given-names>A</given-names></name><name><surname>Volkmer</surname><given-names>R</given-names></name><name><surname>Steinmetz</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Sequence determinants of a microtubule tip localization signal (MtLS)</article-title><source>The Journal of Biological Chemistry</source><volume>287</volume><fpage>28227</fpage><lpage>28242</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.373928</pub-id><pub-id pub-id-type="pmid">22696216</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camacho-Zarco</surname><given-names>AR</given-names></name><name><surname>Schnapka</surname><given-names>V</given-names></name><name><surname>Guseva</surname><given-names>S</given-names></name><name><surname>Abyzov</surname><given-names>A</given-names></name><name><surname>Adamski</surname><given-names>W</given-names></name><name><surname>Milles</surname><given-names>S</given-names></name><name><surname>Jensen</surname><given-names>MR</given-names></name><name><surname>Zidek</surname><given-names>L</given-names></name><name><surname>Salvi</surname><given-names>N</given-names></name><name><surname>Blackledge</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>NMR provides unique insight into the functional dynamics and interactions of intrinsically disordered proteins</article-title><source>Chemical Reviews</source><volume>122</volume><fpage>9331</fpage><lpage>9356</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.1c01023</pub-id><pub-id pub-id-type="pmid">35446534</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Almo</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Falany</surname><given-names>CN</given-names></name><name><surname>Leyh</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The gate that governs sulfotransferase selectivity</article-title><source>Biochemistry</source><volume>52</volume><fpage>415</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1021/bi301492j</pub-id><pub-id pub-id-type="pmid">23256751</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>d’Auvergne</surname><given-names>EJ</given-names></name><name><surname>Gooley</surname><given-names>PR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Optimisation of NMR dynamic models II. A new methodology for the dual optimisation of the model-free parameters and the Brownian rotational diffusion tensor</article-title><source>Journal of Biomolecular NMR</source><volume>40</volume><fpage>121</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1007/s10858-007-9213-3</pub-id><pub-id pub-id-type="pmid">18085411</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshmukh</surname><given-names>L</given-names></name><name><surname>Tugarinov</surname><given-names>V</given-names></name><name><surname>Louis</surname><given-names>JM</given-names></name><name><surname>Clore</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Binding kinetics and substrate selectivity in HIV-1 protease-Gag interactions probed at atomic resolution by chemical exchange NMR</article-title><source>PNAS</source><volume>114</volume><fpage>E9855</fpage><lpage>E9862</lpage><pub-id pub-id-type="doi">10.1073/pnas.1716098114</pub-id><pub-id pub-id-type="pmid">29087351</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>A</given-names></name><name><surname>Konuma</surname><given-names>T</given-names></name><name><surname>Yanaka</surname><given-names>S</given-names></name><name><surname>Sugase</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Quantitative analysis of protein-ligand interactions by NMR</article-title><source>Progress in Nuclear Magnetic Resonance Spectroscopy</source><volume>96</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.pnmrs.2016.02.002</pub-id><pub-id pub-id-type="pmid">27573180</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouveia</surname><given-names>SM</given-names></name><name><surname>Akhmanova</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cell and molecular biology of microtubule plus end tracking proteins: end binding proteins and their partners</article-title><source>International Review of Cell and Molecular Biology</source><volume>285</volume><fpage>1</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-381047-2.00001-3</pub-id><pub-id pub-id-type="pmid">21035097</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honnappa</surname><given-names>S</given-names></name><name><surname>Gouveia</surname><given-names>SM</given-names></name><name><surname>Weisbrich</surname><given-names>A</given-names></name><name><surname>Damberger</surname><given-names>FF</given-names></name><name><surname>Bhavesh</surname><given-names>NS</given-names></name><name><surname>Jawhari</surname><given-names>H</given-names></name><name><surname>Grigoriev</surname><given-names>I</given-names></name><name><surname>van Rijssel</surname><given-names>FJA</given-names></name><name><surname>Buey</surname><given-names>RM</given-names></name><name><surname>Lawera</surname><given-names>A</given-names></name><name><surname>Jelesarov</surname><given-names>I</given-names></name><name><surname>Winkler</surname><given-names>FK</given-names></name><name><surname>Wüthrich</surname><given-names>K</given-names></name><name><surname>Akhmanova</surname><given-names>A</given-names></name><name><surname>Steinmetz</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>An EB1-binding motif acts as a microtubule tip localization signal</article-title><source>Cell</source><volume>138</volume><fpage>366</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.04.065</pub-id><pub-id pub-id-type="pmid">19632184</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>J</given-names></name><name><surname>Hyman</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Dynamics and mechanics of the microtubule plus end</article-title><source>Nature</source><volume>422</volume><fpage>753</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1038/nature01600</pub-id><pub-id pub-id-type="pmid">12700769</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Akhmanova</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Microtubule tip-interacting proteins: a view from both ends</article-title><source>Current Opinion in Cell Biology</source><volume>23</volume><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2010.08.008</pub-id><pub-id pub-id-type="pmid">20817499</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>FI</given-names></name><name><surname>Lan</surname><given-names>D</given-names></name><name><surname>Durrani</surname><given-names>R</given-names></name><name><surname>Huan</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The lid domain in lipases: structural and functional determinant of enzymatic properties</article-title><source>Frontiers in Bioengineering and Biotechnology</source><volume>5</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.3389/fbioe.2017.00016</pub-id><pub-id pub-id-type="pmid">28337436</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kita</surname><given-names>K</given-names></name><name><surname>Wittmann</surname><given-names>T</given-names></name><name><surname>Näthke</surname><given-names>IS</given-names></name><name><surname>Waterman-Storer</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Adenomatous polyposis coli on microtubule plus ends in cell extensions can promote microtubule net growth with or without EB1</article-title><source>Molecular Biology of the Cell</source><volume>17</volume><fpage>2331</fpage><lpage>2345</lpage><pub-id pub-id-type="doi">10.1091/mbc.e05-06-0498</pub-id><pub-id pub-id-type="pmid">16525027</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Wittmann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>+TIPs: SxIPping along microtubule ends</article-title><source>Trends in Cell Biology</source><volume>22</volume><fpage>418</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2012.05.005</pub-id><pub-id pub-id-type="pmid">22748381</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Quan</surname><given-names>L</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>EB1 acts as an oncogene via activating beta-catenin/TCF pathway to promote cellular growth and inhibit apoptosis</article-title><source>Molecular Carcinogenesis</source><volume>48</volume><fpage>212</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1002/mc.20471</pub-id><pub-id pub-id-type="pmid">18680107</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohanty</surname><given-names>P</given-names></name><name><surname>Kapoor</surname><given-names>U</given-names></name><name><surname>Sundaravadivelu Devarajan</surname><given-names>D</given-names></name><name><surname>Phan</surname><given-names>TM</given-names></name><name><surname>Rizuan</surname><given-names>A</given-names></name><name><surname>Mittal</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Principles governing the phase separation of multidomain proteins</article-title><source>Biochemistry</source><volume>61</volume><fpage>2443</fpage><lpage>2455</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.2c00210</pub-id><pub-id pub-id-type="pmid">35802394</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollica</surname><given-names>L</given-names></name><name><surname>Bessa</surname><given-names>LM</given-names></name><name><surname>Hanoulle</surname><given-names>X</given-names></name><name><surname>Jensen</surname><given-names>MR</given-names></name><name><surname>Blackledge</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Binding mechanisms of intrinsically disordered proteins: theory, simulation, and experiment</article-title><source>Frontiers in Molecular Biosciences</source><volume>3</volume><elocation-id>52</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2016.00052</pub-id><pub-id pub-id-type="pmid">27668217</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>OM</given-names></name><name><surname>Torpey</surname><given-names>JH</given-names></name><name><surname>Isaacson</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Intrinsically disordered proteins: modes of binding with emphasis on disordered domains</article-title><source>Open Biology</source><volume>11</volume><elocation-id>210222</elocation-id><pub-id pub-id-type="doi">10.1098/rsob.210222</pub-id><pub-id pub-id-type="pmid">34610267</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shammas</surname><given-names>SL</given-names></name><name><surname>Travis</surname><given-names>AJ</given-names></name><name><surname>Clarke</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Remarkably fast coupled folding and binding of the intrinsically disordered transactivation domain of cMyb to CBP KIX</article-title><source>The Journal of Physical Chemistry. B</source><volume>117</volume><fpage>13346</fpage><lpage>13356</lpage><pub-id pub-id-type="doi">10.1021/jp404267e</pub-id><pub-id pub-id-type="pmid">23875714</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shammas</surname><given-names>SL</given-names></name><name><surname>Crabtree</surname><given-names>MD</given-names></name><name><surname>Dahal</surname><given-names>L</given-names></name><name><surname>Wicky</surname><given-names>BIM</given-names></name><name><surname>Clarke</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Insights into coupled folding and binding mechanisms from kinetic studies</article-title><source>The Journal of Biological Chemistry</source><volume>291</volume><fpage>6689</fpage><lpage>6695</lpage><pub-id pub-id-type="doi">10.1074/jbc.R115.692715</pub-id><pub-id pub-id-type="pmid">26851275</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoup</surname><given-names>D</given-names></name><name><surname>Szabo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Role of diffusion in ligand binding to macromolecules and cell-bound receptors</article-title><source>Biophys J</source><volume>40</volume><fpage>33</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/s0006-3495(82)84455-x</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The microtubule end-binding affinity of EB1 is enhanced by a dimeric organization that is susceptible to phosphorylation</article-title><source>Journal of Cell Science</source><volume>133</volume><elocation-id>jcs241216</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.241216</pub-id><pub-id pub-id-type="pmid">32152183</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name><name><surname>Chi</surname><given-names>C</given-names></name><name><surname>Xiang</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Hill</surname><given-names>DL</given-names></name><name><surname>Fu</surname><given-names>C</given-names></name><name><surname>Yuan</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Zang</surname><given-names>J</given-names></name><name><surname>Hou</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Phase separation of EB1 guides microtubule plus-end dynamics</article-title><source>Nature Cell Biology</source><volume>25</volume><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1038/s41556-022-01033-4</pub-id><pub-id pub-id-type="pmid">36536176</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugase</surname><given-names>K</given-names></name><name><surname>Dyson</surname><given-names>HJ</given-names></name><name><surname>Wright</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mechanism of coupled folding and binding of an intrinsically disordered protein</article-title><source>Nature</source><volume>447</volume><fpage>1021</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1038/nature05858</pub-id><pub-id pub-id-type="pmid">17522630</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallurupalli</surname><given-names>P</given-names></name><name><surname>Bouvignies</surname><given-names>G</given-names></name><name><surname>Kay</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Studying “invisible” excited protein states in slow exchange with a major state conformation</article-title><source>Journal of the American Chemical Society</source><volume>134</volume><fpage>8148</fpage><lpage>8161</lpage><pub-id pub-id-type="doi">10.1021/ja3001419</pub-id><pub-id pub-id-type="pmid">22554188</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaughan</surname><given-names>KT</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>TIP maker and TIP marker; EB1 as a master controller of microtubule plus ends</article-title><source>The Journal of Cell Biology</source><volume>171</volume><fpage>197</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1083/jcb.200509150</pub-id><pub-id pub-id-type="pmid">16247021</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vranken</surname><given-names>WF</given-names></name><name><surname>Boucher</surname><given-names>W</given-names></name><name><surname>Stevens</surname><given-names>TJ</given-names></name><name><surname>Fogh</surname><given-names>RH</given-names></name><name><surname>Pajon</surname><given-names>A</given-names></name><name><surname>Llinas</surname><given-names>M</given-names></name><name><surname>Ulrich</surname><given-names>EL</given-names></name><name><surname>Markley</surname><given-names>JL</given-names></name><name><surname>Ionides</surname><given-names>J</given-names></name><name><surname>Laue</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The CCPN data model for NMR spectroscopy: development of a software pipeline</article-title><source>Proteins</source><volume>59</volume><fpage>687</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1002/prot.20449</pub-id><pub-id pub-id-type="pmid">15815974</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waudby</surname><given-names>CA</given-names></name><name><surname>Ramos</surname><given-names>A</given-names></name><name><surname>Cabrita</surname><given-names>LD</given-names></name><name><surname>Christodoulou</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Two-Dimensional NMR lineshape analysis</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>24826</elocation-id><pub-id pub-id-type="doi">10.1038/srep24826</pub-id><pub-id pub-id-type="pmid">27109776</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>PE</given-names></name><name><surname>Dyson</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Linking folding and binding</article-title><source>Current Opinion in Structural Biology</source><volume>19</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2008.12.003</pub-id><pub-id pub-id-type="pmid">19157855</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Alushin</surname><given-names>GM</given-names></name><name><surname>Brown</surname><given-names>A</given-names></name><name><surname>Nogales</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mechanistic origin of microtubule dynamic instability and its modulation by EB proteins</article-title><source>Cell</source><volume>162</volume><fpage>849</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.07.012</pub-id><pub-id pub-id-type="pmid">26234155</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zumbro</surname><given-names>E</given-names></name><name><surname>Alexander-Katz</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Multivalent polymers can control phase boundary, dynamics, and organization of liquid-liquid phase separation</article-title><source>PLOS ONE</source><volume>16</volume><elocation-id>e0245405</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0245405</pub-id><pub-id pub-id-type="pmid">34748548</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><sec sec-type="appendix" id="s8"><title>TITAN models for fitting EBH titration data</title><p>In general, the dimeric structure of EBH and the location of the binding site at the interface between the monomers requires the use of the dimer binding model with three different states: free EBH, EBH bound to one peptide, and the full complex with two peptides bound. In both the free and the final complex, the chemical shifts of both subunits are identical due to the symmetry of the EBH dimer. However, binding to only one site may have an indirect effect on the chemical shifts of the other site and the appearance of two additional signals at the intermediate points of the titration: one corresponding to the empty and one to the filled site that, which differ from the shifts of the free and fully bound states. The indirect effects on the chemical shifts are usually small, leading to the cross-peaks of the empty site being close to the free state, and the occupied site to the peaks of the fully bound state. These additional cross-peaks can only be observed if the exchange rate is sufficiently slow. In the case of the fast exchange, the presence of the intermediate state can be detected as a complex, non-linear pattern of the chemical shifts (<xref ref-type="bibr" rid="bib35">Waudby et al., 2016</xref>). In such cases, a four-state model is required for the fitting. However, if the indirect effect on the chemical shifts is small and the exchange is fast, the binding to each site can be treated as independent, and the changes in the spectra can be fitted with a two-state binding model.</p><p>We observed different exchange regimes for the interactions of EBH and EBH-ΔC with different MACF peptides, in agreement with the dissociation constants (<xref ref-type="table" rid="table1">Table 1</xref>). The interaction of the 11MACF with EBH-ΔC (ITC <inline-formula><alternatives><mml:math id="inf27"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft27">\begin{document}$K_{D}$\end{document}</tex-math></alternatives></inline-formula> 41.5 ± 8.8 µM) showed gradual chemical shift changes with a significant peak broadening for the largest chemical shift differences, corresponding to the fast-intermediate exchange (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). The majority of the peak trajectories followed a straight line, in agreement with small indirect binding effect and applicability of the two-site binding model. The TITAN analysis with the single site model (independent binding to the two binding sites of the dimer) gave <inline-formula><alternatives><mml:math id="inf28"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft28">\begin{document}$K_{D}$\end{document}</tex-math></alternatives></inline-formula> <italic>=</italic> 26.6 ± 0.051 μM that agreed well with the ITC <inline-formula><alternatives><mml:math id="inf29"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft29">\begin{document}$K_{D}$\end{document}</tex-math></alternatives></inline-formula> and <inline-formula><alternatives><mml:math id="inf30"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft30">\begin{document}$ k_{off}$\end{document}</tex-math></alternatives></inline-formula> = 1900 ± 18 s<sup>−1</sup>, corresponding to the fast exchange. The mutant 11MACF-VLL peptide showed stronger binding by ITC (ITC <inline-formula><alternatives><mml:math id="inf31"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mi>D</mml:mi></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft31">\begin{document}$K_D$\end{document}</tex-math></alternatives></inline-formula> 18.7 ± 3.1 µM). In agreement with this, we observed more pronounced broadening during the NMR titration (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3B</xref>). TITAN analysis of the data gave <inline-formula><alternatives><mml:math id="inf32"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft32">\begin{document}$K_{D}$\end{document}</tex-math></alternatives></inline-formula> = 25.62 ± 0.82 μM that agreed well with the ITC <inline-formula><alternatives><mml:math id="inf33"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft33">\begin{document}$K_{D}$\end{document}</tex-math></alternatives></inline-formula> and <inline-formula><alternatives><mml:math id="inf34"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft34">\begin{document}$k_{off}$\end{document}</tex-math></alternatives></inline-formula> = 1541 ± 79 s<sup>−1</sup>, that was close to the off-rate of the WT peptide. This demonstrated that the affinity increase was caused mainly by the on-rate increase.</p><p>For the significantly stronger interaction of the 11MACF with EBH (ITC <inline-formula><alternatives><mml:math id="inf35"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mi>D</mml:mi></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft35">\begin{document}$K_D$\end{document}</tex-math></alternatives></inline-formula> 3.5 ± 1.0 µM), we observed a combination of intermediate exchange for smaller chemical shift changes and slow exchange for the largest changes in signals of the residues in the binding pocket, particularly in the C-terminal region that becomes immobilised in the complex (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>). In a number of cases, the peak trajectories were not linear, indicating an indirect effect on chemical shifts in one site from the binding of the peptide to the other site. At the lower temperature of 15°C, additional peaks were observed for the intermediate binding state. These signals correspond to the non-symmetrical EBH complex where one binding site is occupied, and the other binding site is empty. Although the two binding sites are located at the opposite sides of the EBH dimer and do not overlap, the peptide binding to one site causes small changes in the EBH structure propagated to the unoccupied site. This, in turn, leads to the small chemical shift changes in the empty site. In a similar way, the binding of the second peptide causes small structural changes in the occupied site and, thus, additional chemical shift changes. As a result, in the non-symmetrical complex with one peptide bound, the signals of free site are different from the signals of the free EBH, and the signals of the bound site are different from the signals of the symmetrical complex with the two peptides bound. This leads to the appearance of additional signals in the intermediate bound state when the exchange is slow, or to non-linear signal behaviour under sufficiently fast exchange conditions. The additional signals confirm the binding to the EBH dimer. The small value of the chemical shift changes induced by the indirect effect shows that the structural changes are very small.</p><p>In the case of non-linear chemical shift changes or appearance of new signals, the single-side binding model cannot reproduce the spectral variations and the dimer four-state binding model with additional parameters has to be used for the fitting. The dimer binding model in TITAN includes cooperativity factors <inline-formula><alternatives><mml:math id="inf36"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mi>log</mml:mi><mml:mo>⁡</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft36">\begin{document}$\alpha =\log (K_{D,2}/ K_D)$\end{document}</tex-math></alternatives></inline-formula> and <inline-formula><alternatives><mml:math id="inf37"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi><mml:mo>=</mml:mo><mml:mi>log</mml:mi><mml:mo>⁡</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft37">\begin{document}$\beta =\log (k_{off,2}/ k_{off})$\end{document}</tex-math></alternatives></inline-formula>, where <inline-formula><alternatives><mml:math id="inf38"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft38">\begin{document}$K_{D,2}$\end{document}</tex-math></alternatives></inline-formula> and <inline-formula><alternatives><mml:math id="inf39"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft39">\begin{document}$k_{off,2}$\end{document}</tex-math></alternatives></inline-formula> are the dissociation constant and off-rate of the second binding, respectively. The fitting of the titration with all parameters showed close to zero values for both cooperativity parameters. We, therefore, fixed their values at zero during the fit to simplify the model. The resulting values of <inline-formula><alternatives><mml:math id="inf40"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>4.9</mml:mn><mml:mo>±</mml:mo><mml:mn>0.1</mml:mn></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft40">\begin{document}$K_D=4.9 \pm 0.1$\end{document}</tex-math></alternatives></inline-formula> μM and <inline-formula><alternatives><mml:math id="inf41"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>130.2</mml:mn><mml:mo>±</mml:mo><mml:mn>2.1</mml:mn><mml:mspace width="thinmathspace"/><mml:msup><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft41">\begin{document}$k_{off}= 130.2 \pm 2.1 \, {\rm s}^{-1}$\end{document}</tex-math></alternatives></inline-formula> were close to the values obtained with the cooperativity parameters (<inline-formula><alternatives><mml:math id="inf42"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>4.8</mml:mn><mml:mo>±</mml:mo><mml:mn>0.1</mml:mn></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft42">\begin{document}$K_D=4.8 \pm 0.1$\end{document}</tex-math></alternatives></inline-formula> μM and <inline-formula><alternatives><mml:math id="inf43"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>130</mml:mn><mml:mo>±</mml:mo><mml:mn>0.7</mml:mn><mml:mspace width="thinmathspace"/><mml:msup><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft43">\begin{document}$k_{off}= 130 \pm 0.7 \, {\rm s}^{-1}$\end{document}</tex-math></alternatives></inline-formula>).</p><p>For the stronger interaction between 11MACF-VLL and EBH (ITC Kd 80 nM), many signals showed slow exchange and clear presence of signals from the intermediate binding state (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>), which required the use of the dimer binding model. In most cases, one of the intermediate state signals was located close to the free, and the other close to the fully bound-state signal, in agreement with a much smaller indirect effect. However, for the residues in the loop between the short and the long helix Gly230, Asn231, Gly233, and Asn235, signals of the intermediate state were significantly more displaced from the signals of the free and fully bonded forms (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>). These residues are located far from the binding site and do not make direct contact with the peptide. The effect on the chemical shifts of these residues indicates some structural rearrangement of the relative positions of the helices induced by the peptide binding to each of the sites.</p><p>The fitting of the 11MACF-VLL titration with all four parameters resulted in <inline-formula><alternatives><mml:math id="inf44"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>66</mml:mn><mml:mspace width="thinmathspace"/><mml:mo>±</mml:mo><mml:mn>2</mml:mn><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">M</mml:mi></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft44">\begin{document}$K_D= 66\,\pm 2\, \rm nM$\end{document}</tex-math></alternatives></inline-formula>, <inline-formula><alternatives><mml:math id="inf45"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>15</mml:mn><mml:mo>±</mml:mo><mml:mn>0.2</mml:mn><mml:mspace width="thinmathspace"/><mml:msup><mml:mrow><mml:mi mathvariant="normal">s</mml:mi></mml:mrow><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft45">\begin{document}$k_{off}= 15 \pm 0.2 \, {\rm s}^{-1}$\end{document}</tex-math></alternatives></inline-formula>, <inline-formula><alternatives><mml:math id="inf46"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft46">\begin{document}$\alpha = 0.5$\end{document}</tex-math></alternatives></inline-formula> and <inline-formula><alternatives><mml:math id="inf47"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:mi>β</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft47">\begin{document}$\beta =0$\end{document}</tex-math></alternatives></inline-formula>, corresponding to a weak negative cooperativity with an ~3-fold increase of the <inline-formula><alternatives><mml:math id="inf48"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft48">\begin{document}$K_{D}$\end{document}</tex-math></alternatives></inline-formula> for the second binding without a change in the dissociation rate. The dissociation constant for the first binding event agreed very well with the ITC dissociation constant of 80 ± 2 nM, supporting the NMR analysis. The negative cooperativity may reflect the small structural rearrangement detected from the chemical shift changes. When the cooperativity parameters were set to zero during the fit, corresponding to the two-state binding model used for ITC, the <inline-formula><alternatives><mml:math id="inf49"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msub><mml:mi>K</mml:mi><mml:mi>D</mml:mi></mml:msub></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft49">\begin{document}$K_D$\end{document}</tex-math></alternatives></inline-formula> value increased to 200 ± 4 nM, while the dissociation rate remained unchanged. The lack of the systematic deviations between the experimental ITC data and the single-site analysis model shows that the difference between the first and the second site binding, if it exists, is too small to be detected by ITC, in line with the weak cooperativity observed by NMR. We therefore concluded that while NMR gives indication of the weak negative cooperativity, the differences in the binding affinities for the first and second ligand binding events are too small for a reliable interpretation, and the single-site binding model should be used to avoid overfitting and overinterpretation.</p></sec><sec sec-type="appendix" id="s9"><title>Exchange approximation for low population of the intermediate state</title><p>From <inline-formula><alternatives><mml:math id="inf50"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>K</mml:mi><mml:mi>D</mml:mi><mml:mo>′</mml:mo></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft50">\begin{document}$K'_D$\end{document}</tex-math></alternatives></inline-formula> and <inline-formula><alternatives><mml:math id="inf51"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft51">\begin{document}$k'_{off}$\end{document}</tex-math></alternatives></inline-formula> values for the EBH/11MACF interaction, we can estimate <inline-formula><alternatives><mml:math id="inf52"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>K</mml:mi><mml:mi>D</mml:mi><mml:mi>L</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0.08</mml:mn><mml:mo>−</mml:mo><mml:mn>0.07</mml:mn></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft52">\begin{document}$K_D^L= 0.08- 0.07$\end{document}</tex-math></alternatives></inline-formula>, showing that only ~8% of the bound population is in the intermediate dock state. Since the intensities of the NMR signals corresponding to the intermediate state are proportional to the population of this state, its contribution to the spectra is negligibly small compared to the fully bound state and can be neglected. Under this condition, the measured line shape changes and CEST saturation transfer are only associated with the exchange between the free and the fully bound forms. These rates can be calculated as the overall fluxes between the states using the steady-state conditions as (<xref ref-type="bibr" rid="bib28">Shoup and Szabo, 1982</xref>):<disp-formula id="equ4"><label>(A1)</label><alternatives><mml:math id="m4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:mspace width="thinmathspace"/><mml:mfrac><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t4">\begin{document}$$\displaystyle k'_{on} = k_{on}^{D} \, \frac{k_{on}^{L}}{k_{off}^{D} + k_{on}^{L}}$$\end{document}</tex-math></alternatives></disp-formula><disp-formula id="equ5"><label>(A2)</label><alternatives><mml:math id="m5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:mspace width="thinmathspace"/><mml:mfrac><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t5">\begin{document}$$\displaystyle k'_{off} = k_{off}^{D} \, \frac{k_{off}^{L}}{k_{off}^{D} + k_{on}^{L}} $$\end{document}</tex-math></alternatives></disp-formula></p><p>The effective dissociation constant between these states is then:<disp-formula id="equ6"><label>(A3)</label><alternatives><mml:math id="m6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup></mml:mrow><mml:mspace width="thinmathspace"/><mml:mo>∗</mml:mo><mml:mspace width="thinmathspace"/><mml:mrow><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t6">\begin{document}$$\displaystyle {K_{D}'} = {K_{D}^{D}} \, * \, {K_{D}^{L}}$$\end{document}</tex-math></alternatives></disp-formula></p><p>which agrees with <xref ref-type="disp-formula" rid="equ1">Equation 1</xref> when <inline-formula><alternatives><mml:math id="inf53"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>K</mml:mi><mml:mi>D</mml:mi><mml:mi>D</mml:mi></mml:msubsup><mml:mo>≪</mml:mo><mml:mn>1</mml:mn></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft53">\begin{document}$K_D^D\ll 1$\end{document}</tex-math></alternatives></inline-formula>.</p><p><xref ref-type="disp-formula" rid="equ3">Equation 3</xref> can be rearranged:<disp-formula id="equ7"><label>(A4)</label><alternatives><mml:math id="m7"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:mspace width="thinmathspace"/><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mfrac><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mfrac><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t7">\begin{document}$$\displaystyle k'_{on} = k_{on}^{D} \, \frac{1}{\frac{k_{off}^{D}}{k_{on}^{L}} + 1}$$\end{document}</tex-math></alternatives></disp-formula></p><p>Since<disp-formula id="equ8"><label>(A5)</label><alternatives><mml:math id="m8"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mfrac><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi></mml:mrow></mml:msubsup></mml:mfrac><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:mo>≤</mml:mo><mml:mn>1</mml:mn></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t8">\begin{document}$$\displaystyle \frac{1}{\frac{k_{off}^{D}}{k_{on}^{L}} + 1} \le 1$$\end{document}</tex-math></alternatives></disp-formula></p><p>then<disp-formula id="equ9"><label>(A6)</label><alternatives><mml:math id="m9"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup><mml:mo>≤</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t9">\begin{document}$$\displaystyle k'_{on} \le k_{on}^{D}$$\end{document}</tex-math></alternatives></disp-formula></p><p>From this equation, the additional exchange step caused by the conformation change of the complex should generally lead to a reduction in the on-rate for the full transition to the complex. In the case of a very fast transfer from the intermediate to the fully bound state compared to the ligand dissociation from the transition state (<inline-formula><alternatives><mml:math id="inf54"><mml:mstyle><mml:mrow><mml:mstyle displaystyle="false"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mi>D</mml:mi></mml:msubsup><mml:mo>≪</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mi>L</mml:mi></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="inft54">\begin{document}$k^D_{off} \ll k^L_{on}$\end{document}</tex-math></alternatives></inline-formula>), the initial dock step becomes rate-limited, with overall on-rate equal to the on-rate of the dock step.</p><p>From <xref ref-type="disp-formula" rid="equ1 equ2">Equations 1 and 2</xref> of the main text,<disp-formula id="equ10"><label>(A7)</label><alternatives><mml:math id="m10"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup></mml:mfrac></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:msubsup><mml:mi>K</mml:mi><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup></mml:mfrac></mml:mrow></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t10">\begin{document}$$\displaystyle {\frac{K_{D}'}{k_{off}'}} = {\frac{K_{D}^{D}}{k_{off}^{D}}}$$\end{document}</tex-math></alternatives></disp-formula></p><p>and<disp-formula id="equ11"><label>(A8)</label><alternatives><mml:math id="m11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:msubsup><mml:mi>k</mml:mi><mml:mrow><mml:mi>o</mml:mi><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:msubsup></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t11">\begin{document}$$\displaystyle k'_{on} = k_{on}^{D}$$\end{document}</tex-math></alternatives></disp-formula></p><p>So, the equality of the on-rates also holds under fast exchange in the second lock step even if the population of the intermediate state is not negligibly small.</p><p>When the population of the intermediate state is comparable to the population of the fully bound state and the exchange in the second lock step is intermediate or slow, the binding cannot be approximated by a two-site model and the intermediate step should be considered explicitly. Under these conditions, NMR signals of the fully titrated protein will have an exchange contribution or additional signals corresponding to intermediate states will be observed. This will allow direct evaluation of the exchange parameters of the second lock step from the NMR analysis.</p><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>NMR restraints and structure statistics for the NMR structure of the EBH/11MACF complex.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" colspan="2">Total restraints used</th></tr></thead><tbody><tr><td align="left" valign="top">NOE restraints<xref ref-type="table-fn" rid="app1table1fn1">*</xref></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">All</td><td align="left" valign="top">3863</td></tr><tr><td align="left" valign="top">Protein-ligand</td><td align="left" valign="top">298</td></tr><tr><td align="left" valign="top">Intermonomer</td><td align="left" valign="top">924</td></tr><tr><td align="left" valign="top">Intrapeptide</td><td align="left" valign="top">209</td></tr><tr><td align="left" valign="top">Intraresidue</td><td align="left" valign="top">1133</td></tr><tr><td align="left" valign="top">Sequential (|i – j|=1)</td><td align="left" valign="top">968</td></tr><tr><td align="left" valign="top">Medium (1 &lt; |i – j|≤4)</td><td align="left" valign="top">1311</td></tr><tr><td align="left" valign="top">Long range (|i – j|&gt;4)</td><td align="left" valign="top">177</td></tr><tr><td align="left" valign="top">Dihedral</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Φ angles</td><td align="left" valign="top">65</td></tr><tr><td align="left" valign="top">φ angles</td><td align="left" valign="top">65</td></tr><tr><td align="left" valign="top">Hydrogen bonds</td><td align="left" valign="top">90</td></tr><tr><td align="left" valign="top" colspan="2">Structure statistics</td></tr><tr><td align="left" valign="top" colspan="2">Violations</td></tr><tr><td align="left" valign="top">Distance (&gt;0.5 Å)</td><td align="left" valign="top">41</td></tr><tr><td align="left" valign="top">Dihedral angle (&gt;5°)</td><td align="left" valign="top">7</td></tr><tr><td align="left" valign="top" colspan="2">Energies (cal/mol)</td></tr><tr><td align="left" valign="top">Overall</td><td align="left" valign="top">–2179 (±208)</td></tr><tr><td align="left" valign="top">Bond</td><td align="left" valign="top">119 (±9)</td></tr><tr><td align="left" valign="top">Angle</td><td align="left" valign="top">479 (±21)</td></tr><tr><td align="left" valign="top">Improper</td><td align="left" valign="top">242 (±29)</td></tr><tr><td align="left" valign="top">Dihedral</td><td align="left" valign="top">868 (±14)</td></tr><tr><td align="left" valign="top">Van der Waals</td><td align="left" valign="top">–48 (±28)</td></tr><tr><td align="left" valign="top">Electrostatic</td><td align="left" valign="top">–5903 (±98)</td></tr><tr><td align="left" valign="top">NOE</td><td align="left" valign="top">1906 (±119)</td></tr><tr><td align="left" valign="top">Geometry – average values</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Bond</td><td align="left" valign="top">7.40x10<sup>–3</sup> (±5.7 × 10<sup>–4</sup>)</td></tr><tr><td align="left" valign="top">Angle</td><td align="left" valign="top">0.91 (±9.96 × 10<sup>–2</sup>)</td></tr><tr><td align="left" valign="top">Improper</td><td align="left" valign="top">2.50 (±0.30)</td></tr><tr><td align="left" valign="top">Dihedral</td><td align="left" valign="top">41.56 (±0.24)</td></tr><tr><td align="left" valign="top">Van der Waals</td><td align="left" valign="top">428.93 (±83.98)</td></tr><tr><td align="left" valign="top">Average pairwise RMSD (Å)<sup><xref ref-type="table-fn" rid="app1table1fn2">†</xref></sup></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Heavy atoms</td><td align="left" valign="top">2.41 (±1.25)</td></tr><tr><td align="left" valign="top">Heavy atoms – helical region</td><td align="left" valign="top">1.51 (±0.99)</td></tr><tr><td align="left" valign="top">Backbone</td><td align="left" valign="top">2.05 (±1.33)</td></tr><tr><td align="left" valign="top">Backbone – helical region</td><td align="left" valign="top">1.08 (±0.93)</td></tr><tr><td align="left" valign="top">Ramachandran statistics (%) <sup><xref ref-type="table-fn" rid="app1table1fn3">‡</xref></sup></td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Most favoured regions</td><td align="left" valign="top">87.0 (99.5)</td></tr><tr><td align="left" valign="top">Additional allowed regions</td><td align="left" valign="top">10.8 (0.3)</td></tr><tr><td align="left" valign="top">Generously allowed regions</td><td align="left" valign="top">1.0 (0.2)</td></tr><tr><td align="left" valign="top">Disallowed regions</td><td align="left" valign="top">1.1 (0)</td></tr></tbody></table><table-wrap-foot><fn id="app1table1fn1"><label>*</label><p>Number in brackets corresponds to the restraints assigned manually.</p></fn><fn id="app1table1fn2"><label>†</label><p>Helical region corresponds to residues: Glu192-Glu230 and Pro237-Tyr247.</p></fn><fn id="app1table1fn3"><label> ‡</label><p>Values within brackets correspond to residues Glu192-Glu230 and Pro237-Tyr247 (helical region).</p></fn></table-wrap-foot></table-wrap></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98063.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Roche</surname><given-names>Julien</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Iowa State University</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This study provides <bold>important</bold> insights into how the EBH domain of microtubule end-binding protein 1 (EB1) interacts with SxIP peptides derived from the MACF plus-end tracking protein. The revised manuscript includes <bold>convincing</bold> ITC and NMR experiments that clarify the role of flanking residues and address the influence of dimerization and cooperativity on binding. While some mechanistic aspects remain difficult to resolve experimentally, the data and analysis now more clearly justify the proposed &quot;dock-and-lock&quot; model and its interpretive value. This work will be of interest to structural biologists and biophysicists studying microtubule-associated protein interactions.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98063.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In this article, Almeida and colleagues use a combination of NMR and ITC to study the interaction of the EBH domain of microtubule end-binding protein 1 (EB1) with SxIP peptides derived from the MACF plus-end tracking protein. EBH forms a dimer and in isolation has previously been shown to have a disordered C-terminal tail. Here, the authors use NMR to determine a solution structure of the EBH dimer bound to 11-mer SxIP peptides derived from MACF, and observe that the disordered C-terminal of EBH is recruited by residues C-terminal to the SxIP motif to fold into the final complex. By comparison of binding in different length peptides, and of EBH lacking the C-terminal tail, they show that these additional contacts increase binding affinity by an order of magnitude, greatly stabilising the interaction, in a binding mode they term 'dock-and-lock'.</p><p>The authors also use their new structural knowledge to design peptides with higher affinities, and show in a cell model that these can be weakly recruited to microtubule ends - although a dimeric construct is necessary for efficient recruitment. Ultimately, by demonstrating the feasibility of targeting these proteins, this work points towards the possibility of designing small-molecules to block the interactions.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98063.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The C-terminal region of EB1 is responsible for protein-protein interactions, thereby recruiting the binding partners of EB1 to microtubules; the coiled-coil region (EBH) and the acidic tail are critical for their binding partners. The authors demonstrated by using NMR that the binding mode of EBH with the SxIP motif, which is a two-step process termed &quot;dock-and-lock&quot;. The ITC analysis supports the results obtained from NMR. The initial version of the manuscript contained ambiguities on the ITC data; however, the results of the revised manuscript are convincing and support the two-step binding model.</p><p>Strength:</p><p>The authors propose a novel model of &quot;dock-and-lock&quot; by using multiple methods of NMR, ITC and cell biology.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.98063.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Almeida</surname><given-names>Teresa</given-names></name><role specific-use="author">Author</role><aff><institution>University of Liverpool</institution><addr-line><named-content content-type="city">Liverpool</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Hargreaves</surname><given-names>Eleanor</given-names></name><role specific-use="author">Author</role><aff><institution>University of Liverpool</institution><addr-line><named-content content-type="city">Liverpool</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Zech</surname><given-names>Tobias</given-names></name><role specific-use="author">Author</role><aff><institution>University of Liverpool</institution><addr-line><named-content content-type="city">Liverpool</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Barsukov</surname><given-names>Igor</given-names></name><role specific-use="author">Author</role><aff><institution>University of Liverpool</institution><addr-line><named-content content-type="city">Liverpool</named-content></addr-line><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews</p><p>We would like to express our sincere gratitude to the reviewers for their thorough analysis of the manuscript and their extremely helpful comments. We have taken all the suggestions into consideration and conducted a range of additional experiments to address the points raised. We have also extensively revised the manuscript to clarify descriptions, correct inaccuracies and remove inconsistencies. We have modified the figures for clarity and content.</p><p>Overall, we expanded the description of the EBH structure to emphasise its dimeric nature and the impact of the two binding sites on interpreting the binding data, including cooperativity. Using ITC, we tested the effect of the pre-SxIP residues on the binding affinity with additional peptides. We found that these residues had a significant effect, albeit much smaller than that of the post-SxIP residues. We analysed the binding of the 11MACF-VLL mutant with EBH-ΔC and evaluated the exchange rates. In agreement with our model, we found that the EBH affinity for the SxIP peptide from CK5P2 (KKSRLPRILIKRSR), which has a C-terminal sequence similar to that of the 11MACF-VLLRK mutant, is 21nM, which is similar to the affinity of the mutant itself. This demonstrates the significant variation in affinity observed among natural SxIP ligands, as predicted by our study. Our responses to the specific points raised by the reviewers are provided below.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public Review):</bold></p><p>There is no direct experimental evidence for independent dock and lock steps. The model is certainly plausible given their structural data, but all titration and CEST measurements are fully consistent with a simple one-step binding mechanism. Indeed, it is acknowledged that the results for the VLL peptide are not consistent with the predictions of this model, as affinity and dissociation rates do not co-vary. The model may still be a helpful way to interpret and discuss their results, and may indeed be the correct mechanism, but this has not yet been proven.</p></disp-quote><p>Unfortunately, it is not possible to obtain direct experimental evidence because the folding of the C-terminus is too fast to influence the NMR parameters. However, as the reviewer pointed out, our structural data support the two-step model, since folding of the C-terminus is only possible once the ligand containing the post-SxIP residues has bound. By adopting a mechanistically supported model, we can analyse the contributions to binding and relate them to the structural characteristics of the complex. This provides a clearer insight into the roles of the various regions in the interaction and allows to modify them rationally to enhance the ligand affinity.</p><p>In the revised version, we restate the equations in terms of comparing the on-rates. This provides a clearer view of the effect of the additional stage, which cannot increase the overall on-rate since the two stages are sequential. If the forward rate of the second stage is comparable to or slower than the off-rate of the first stage, the overall on-rate decreases. Conversely, if the forward rate is much faster, the overall on-rate remains unchanged. For the wild-type 11MACF peptide, we observed that the presence of the EBH C-terminus does not affect the on-rate of binding, which is in perfect agreement with the two-step model and indicates that the C-terminus folds very quickly.</p><p>Additionally, we evaluated the binding of the 11MACF-VLL mutant to EBH-ΔC and observed a twofold decrease in Kd compared to WT 11MAC, primarily due to an increase in the on-rate. Interestingly, this rate is approximately twice as low as the overall on-rate for EBH/11MACF-VLL binding, contradicting the sequential two-step model. This suggests a more complex binding process where binding is accelerated by additional hydrophobic interactions with the unfolded C-terminus. However, given the difficulty of quantifying very slow exchange rates, it is more likely that the discrepancy is due to the accuracy of the rate measurements. Therefore, the model allows the rational analysis of changes in binding parameters due to mutations.</p><disp-quote content-type="editor-comment"><p>There is little discussion of the fact that binding occurs to EBH dimers - either in terms of the functional significance of this or in the acquisition and analysis of their data. There is no discussion of cooperation in binding (or its absence), either in the analysis of NMR titrations or in ITC measurements. Complete ITC fit results have not been reported so it is not possible to evaluate this for oneself.</p></disp-quote><p>We added information about the dimer to the introduction, emphasising its role in enhancing interaction with microtubules (MTs) and its structural role in SxIP binding. The ITC data do not exhibit any biphasic behaviour and can be fitted to a single-site model with 1:1 stoichiometry relative to the EB1c monomer. This corresponds to two independent binding sites in the dimer. We have added the stoichiometry to Table 1 and the description. The NMR titration data for the 11MACF and 11MACF-VLL interactions were fitted to the TITAN dimer model, which includes cooperativity parameters. For WT 11MACF, both cooperativity parameters were zero, corresponding to independent binding sites in the ITC model. For 11MACF-VLL, the fitting suggests weak negative cooperativity, with a ~3-fold increase in Kd for binding to the second site and no change in the off-rate. This difference in Kd is likely to be too small to induce a biphasic shape to the ITC curve. As the cooperativity effect on the NMR spectra is small and absent in the ITC, we used the independent sites model for data analysis, as there is insufficient justification for introducing extra parameters into the model. Crucially, fitting to this model did not alter the off-rate value obtained by NMR or affect the conclusions. We added a description of cooperativity to the results and discussion.</p><disp-quote content-type="editor-comment"><p>Three peptides are used to examine the role of C-terminal residues in SxIP motifs: 4-MACF (SKIP), 6-MACF (SKIPTP), and 11-MACF (KPSKIPTPQRK). The 11-mer demonstrates the strongest binding, but this has added residues to the N-terminal as well. It has also introduced charges at both termini, further complicating the interpretation of changes in binding affinities. Given this, I do not believe the authors can reasonably attribute increased affinities solely to post-SxIP residues.</p></disp-quote><p>We tested the 9MACF peptide SKIPTPQRK, which has the same N-terminus as the 4- and 6-MACF peptides, and found that its binding affinity is ~10-fold weaker than that of 11MACF. This demonstrates the contribution of both the pre- and post-SxIP residues. This is likely due to electrostatic interactions between the positively charged N-terminus and the negatively charged EBH surface, similar to those involving the positive charges at the peptide C-terminus. Although significant, the contribution of the N-terminal peptide region is approximately one order of magnitude lower than that of the post-SxIP residues, meaning the post-SxIP region is the main affinity modulator. We have added the binding data on 9MACF and a discussion of the contributions to the manuscript.</p><disp-quote content-type="editor-comment"><p>Experimental uncertainties are, with exceptions, not reported.</p></disp-quote><p>Uncertainties added to the number in Table 1 and the text. Information on how uncertainties were calculated added to Table 1.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>(1) Have you tested the binding of the WT dimer in your cell model?</p></disp-quote><p>We haven’t tested the WT dimer because it has already been reported in the 2009 Cell paper by Honappa et al. In the cell experiments, our main focus was on recruiting the high-affinity mutant to MTs. The low level of recruitment, despite the mutant's high affinity, highlights the importance of dimerisation or additional contributions to binding.</p><disp-quote content-type="editor-comment"><p>(2) Please deposit all NMR dynamics measurements (relaxation rates and derived model-free parameters) alongside structural data in the BMRB.</p></disp-quote><p>The relaxation data have been submitted to BMRB, IDs 53187 and 53188</p><disp-quote content-type="editor-comment"><p>(3) Please report complete fitting results, e.g. for ITC, including stoichiometries. Clarify what this means for binding to a dimer, and if there is any evidence of cooperativity. Figure 3C, right hand panel, shows an unusual stoichiometry, can the authors comment on this?</p></disp-quote><p>We have added more information on stoichiometry and cooperativity; please refer to our response to the above comment for details. We repeated the titration for the VLLRK mutant using fresh peptide stock. As expected, the stoichiometry was close to 1:1 relative to the EB1c monomer. The new data are now included in the table and figure.</p><disp-quote content-type="editor-comment"><p>(4) Please report uncertainties for all measurements of Kd, koff, kon, ∆G, ∆H, ∆S, and explain whether these are determined from statistical analysis, technical or biological repeats (and where reported, clarify between standard deviation/standard error). Please also be aware of standard guidelines for reporting significant figures for data with uncertainties, as these have not been followed in Table 1.</p></disp-quote><p>Uncertainties added to the number in Table 1 and the text. Information on how uncertainties were calculated added to Table 1.</p><disp-quote content-type="editor-comment"><p>(5) The construct design for the cell model is unclear - given the importance of flanking residues, please report and discuss how the sequences are attached to venus: which termini is attached, and what is the linker composition?</p></disp-quote><p>We cloned the peptides at the C-terminus of mTFP, after the GS linker of the vector. The peptide itself contains a GS sequence at the N-terminus, creating a highly flexible GSGS linker that separates the SxIP region from mTFP and minimises the potential effect of mTFP on binding. We followed the design of Honappa et al. to enable direct comparison with the published results. We have added this information to the 'Methods' section..</p><disp-quote content-type="editor-comment"><p>(6) Which HSQC pulse sequence was used for 2D lineshape analysis? The authors mention non-linear chemical shift changes, presumably associated with the dimer interface - this would be useful to expand upon and clarify.</p></disp-quote><p>For the lineshape analysis, we used the standard Bruker sequence hsqcfpf3gpphwg with soft-pulse watergate water suppression and flip-back. This sequence is included in the TITAN model. We added the description of the non-linear chemical shift changes and connection of these changes to the allosteric effect of the binding to the supplementary information describing details of the lineshape analysis.</p><disp-quote content-type="editor-comment"><p>(7) Figure 1A could usefully highlight the dimer interface in the surface representation also.</p></disp-quote><p>We believe that including the interface would make the figure too complicated. The dimer configuration is shown in different colours for the two subunits, clearly demonstrating their involvement in forming the binding site.</p><disp-quote content-type="editor-comment"><p>(8) Figures 1C and 1D could usefully show a secondary structure schematic to assist the reader. The x-axis in these figures is not linear and this should be corrected. The calculation of combined chemical shift perturbations should be described.</p></disp-quote><p>Thank you for the helpful suggestion. We changed the scale of the figures and added the diagram of the secondary structure.</p><disp-quote content-type="editor-comment"><p>(9) Units are missing from many figure axes.</p></disp-quote><p>We added missing units to the axes. Thank you for highlighting this.</p><disp-quote content-type="editor-comment"><p>(10) What peptide concentrations are used in Figure 1C? Presumably, these should be reported at saturation for this to be a fair comparison, this should be clarified.</p></disp-quote><p>The protein concentration was 50 µM. Peptides 4MACF and 6MACF were added at a 100-fold molar excess and peptide 11MACF was added at a 4-fold excess. Saturation was achieved for 11MACF. This was impossible for the short peptides due to their mM affinity. This information has been added to the figure legend. The figure's main aim is to illustrate the differences in the chemical shift perturbation profiles, which can be achieved even if full saturation is not attained. Although the absolute value of the chemical shifts is proportional to the degree of saturation, the distribution of the largest chemical shift changes is independent of this degree. Therefore, we can draw conclusions about the distribution of changes by comparing under non-saturation conditions.</p><disp-quote content-type="editor-comment"><p>(11) The presentation of raw peak intensities in Figure 1D shows primarily the flexibility of the C-terminal region associated with high intensities. Beyond this, when comparing the binding of peptides it would be much more informative to show relative peak intensities. Residues around 210-225 appear to show strong broadening in the presence of peptide, but this is masked by the low initial intensity. Can the authors clarify and discuss this? Also, what peptide concentrations were used for this comparison? For a fair comparison, it should be close to saturation - particularly to exclude exchange broadening contributions.</p></disp-quote><p>The protein concentration was 50 µM. 6MACF and 6MACF peptides were added at a 100-fold excess and 11MACF at a 4-fold excess. Saturation was achieved for 11MACF. This was impossible to achieve for the short peptide due to its mM affinity. This information has been added to the figure legend. Upon checking the data, we found a small systematic offset in the coiled-coil region of some of the complexes, as the integral intensity had been used in the initial plot. While this does not change the conclusion regarding the high dynamics of the C-terminus, it does create an inaccurate perception of the relative intensities of the folded regions in the different complexes, as noted by the reviewer. We have now plotted the amplitudes at the maximum of the peaks, which do not exhibit any systematic offset as they are much less susceptible to baseline distortions. We are grateful to the reviewer for highlighting this apparent discrepancy.</p><disp-quote content-type="editor-comment"><p>(12) Figure 2 - the scale for S2 order parameters appears to be backwards, given the caption, but its range should be indicated. Similarly, the range of values for Rex should also be indicated. These data should also be tabulated/plotted in supporting information.</p></disp-quote><p>We have corrected the figure legend and added S2 and Rex plots to the supplementary material. The figure aims to highlight regions of increased mobility, while the plots provide full quantitative information on the values. We thank the reviewer for pointing out the error in the figure legend and for the suggestions regarding the plots.</p><disp-quote content-type="editor-comment"><p>(13) The scale in Figure 3B is illegible. Indeed, the whole structure is quite small and could usefully be expanded.</p></disp-quote><p>We increased the size of the structure panels and added a scale.</p><disp-quote content-type="editor-comment"><p>(14) Figure 4 does not show a decrease in exchange rates, as per the caption - no comparison of exchange rates is shown, only thermodynamic information in panel E. Panel C shows CEST measurements, but it is not clear what system this is for - please clarify, and consider showing the comparable data for the ∆C construct for comparison.</p></disp-quote><p>We have amended the figure legend to clarify that the figure shows binding parameters. We added information about the CEST profiles for the EBH/11MACF interaction to the figure legend (Figure 4C). Exchange with the ∆C construct is too fast for CEST measurements. We used lineshape analysis to evaluate the exchange rates for this construct.</p><disp-quote content-type="editor-comment"><p>(15) The schematics shown in Figure 4D, and elsewhere, are really quite difficult to understand. They may pose additional challenges to colourblind readers. Please consider ways that this could be clarified.</p></disp-quote><p>We simplified the colour scheme in the model to make the colours easier to see and to highlight SxIP and non-SxIP regions. We believe that this improved the clarity of the figure.</p><disp-quote content-type="editor-comment"><p>(16) Figures S1D/E - the x-axes are unclear and units are missing from the y-axes.</p></disp-quote><p>We re-labelled the axes to clarify the scale and units. Thank you for pointing this.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>The C-terminal tail of EB1, which is adjacent to EBH and is not analyzed in this study, is highly acidic and plays an important role in protein interactions. If the authors discuss the C-terminus of EB1, they should analyze the whole C-terminus of EB1, which would strengthen the conclusion they have made.</p></disp-quote><p>Honapa et al., Cell, 2009, reported chemical shift perturbations (CSPs) on the peptide binding for the full EB1c fragment, which includes the negatively charged C-terminus. Similar to our study, they observed significant CSPs in the FVIP region but negligible CSPs at the negatively charged EEY end. They concluded that the final eight EB1c residues did not contribute to binding and used a truncated EB1c construct for their structural analysis. Building on that study, we used the same EEY-truncated construct to analyse the contribution of the C-terminus in more detail. We believe that conducting additional experiments with the full C-terminus with respect to SxIP binding would be superfluous, as it would merely replicate the findings of Honapa EA. We have added the rationale for selecting the truncated EB1c construct to the text, referencing Honapa et al.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>(1) Figure 2C: The authors can analyze the 11MACF peptide as well, to provide more assurance to their argument. It would be easier to distinguish the sequences of &quot;SKIP&quot; and &quot;FVIP&quot; by changing their colors.</p></disp-quote><p>Our relaxation analysis (Fig. 2C) focuses on the dynamics of the unstructured C-terminal region in both the free and complex forms. Further relaxation analysis of the peptide would not provide additional information on this, and would be complicated by the presence of free peptide in solution.</p><disp-quote content-type="editor-comment"><p>(2) Figure 3B: Acidic residues in EBH should be labeled.</p><p>Page 6, line 11: If the authors insist that the acidic patch will influence the interactions between EB1 and the peptide, the data of the analysis using the entire EB1 C-terminus should be included, given that the C-terminal tail of EB1 is highly acidic.</p></disp-quote><p>To test the contribution of charge to binding, we conducted an ITC experiment at increasing salt concentrations. We observed a significant increase in Kd values when the concentration of NaCl increased from 50 to 150 mM, which supports our conclusion regarding the significant electrostatic contribution. This conclusion is independent of the presence or absence of the C-terminus.</p><p>As we explained earlier, Honapa et al., Cell 2009, conducted an NMR experiment on the full EB1c and observed no CPSs in the EEY region, indicating a negligible contribution from the EEY region to SxIP binding. Therefore, we think that additional experiments involving the entire C-terminus are unnecessary, as they would simply replicate the results of Honapa et al. We have added the rationale for selecting the truncated EB1c to the text, referencing Honapa et al.</p><p>It would be very difficult to label the acidic residues without enlarging 3B considerably. However, we do not think this is necessary as we are not discussing any specific residues. The current figure shows the distribution of the surface charge, which is sufficient for our purposes.</p><disp-quote content-type="editor-comment"><p>(3) Figure 2B (Page 4, line 27): The side chain of S5477 should be drawn. The authors should include a figure of the crystal structure of EBH and SxIP as a comparison (Honnappa et al., Cell, 2009). In their paper, Honnappa et al. performed chemical shift perturbation titrations by NMR. From their analysis, I imagine that the EB1 tail may not be critical for the EB1 C-terminus:SxIP interactions, since the signals in the tail are not significantly perturbed. The authors should cite this paper.</p></disp-quote><p>We are grateful to the reviewer for highlighting this. CSP analysis of the Honapa EA revealed significant changes in the FVIP region, which we also observed. They also reported negligible CSPs at the EEY end, demonstrating that this part of the tail is non-critical and can be removed. We have added text to the manuscript to highlight the similarity between CSPs and those observed in Honapa EA. Figure 2B shows the side chains for the residues with the strongest detected contacts. These do not include S5477.</p><disp-quote content-type="editor-comment"><p>(4) Figure 3C (ITC data): The stoichiometric ratios in the ITC data look strange. EBH vs KPSKIPVLLRKRK, is it 1:1?</p></disp-quote><p>We repeated the ITC experiments using a new stock of the peptide and a new batch of the protein, checking the concentrations using UV spectroscopy. The new experiments produced a stoichiometry close to 1, as shown in the table.</p><disp-quote content-type="editor-comment"><p>(5) Page 10, line 27: &quot;The TPQ sequence of 11MACF is not optimal...&quot;: What is the meaning of &quot;optimal&quot;? The transient interaction between EB1 and its binding partner is responsible for the dynamics of the microtubule cytoskeleton. In a sense, the relatively weak interaction is &quot;optimal&quot; for the system. The authors should rephrase the word.</p></disp-quote><p>We agree that weak interactions are optimal from a functional perspective, as they have been selected through evolution. In our case, 'optimal' refers to the hydrophobic interaction with the C-terminus. We replaced 'optimal' with 'ideal' to draw more attention to the second part of the sentence, which clarifies the context.</p><disp-quote content-type="editor-comment"><p>(6) Page 11, line 2: &quot;small number of comets enriched in the peptide that were too faint for the quantitative analysis, comparable to the reported previously (Honnappa, Gouveia et al. 2009).&quot; Honnappa et al. used EGFP-fusion constructs in their study: EGFP forms a weak dimer, which presumably gave different results from the authors' mTFP-constructs. The authors can note this point in the text.</p></disp-quote><p>We are grateful to the reviewer for highlighting this. This aligns well with our conclusion that dimerisation is important for localisation to comets. We have added this point to the text.</p><disp-quote content-type="editor-comment"><p>(7) Page 10, line 21: The authors calculate the free energy of complex formation between EBH and MACF peptide and explain in the text, but it is hard to follow.</p></disp-quote><p>We simplified and clarified the description of the energy contributions by focusing on the SxIP and non-SxIP regions of the peptide, as well as the EBH C-terminus.</p><disp-quote content-type="editor-comment"><p>Minor points:</p><p>Page 2, line 9: IP motifs are not usually located in the C-terminus. For example, SxIP in Tastin is located in the N-terminal region, and SxIPs in CLASP are in the middle.</p></disp-quote><p>We corrected this statement, removing C-terminal.</p><disp-quote content-type="editor-comment"><p>Page 3, line 4: The authors should note the residue numbers of SKIP.</p></disp-quote><p>We think that in this context the residue number of the SxIP region are not important and would be distracting.</p><disp-quote content-type="editor-comment"><p>Figure 3D and Figure S3F: Make the colors and the order the same between the two figures.</p></disp-quote><p>We changed the colour scheme and the order of ITC parameters in S3F to match the main figure.</p><disp-quote content-type="editor-comment"><p>Figure 1A, 2B, Figure S5: Change the color of SKIP from other residues in the same chain, otherwise the readers cannot distinguish. Likewise, change the color of FVIP in Figure 2B.</p></disp-quote><p>We think that changing the colours will complicate the figures unnecessary. The corresponding residues are clearly labelled in the figures.</p><disp-quote content-type="editor-comment"><p>Figure 3, Figure S5, S6, S7: Box the letters of SKIP for clarity.</p></disp-quote><p>We boxed the SxIP region in S5 (new S6) and underlined in S6 (new S7). In S7 (new S8) the location of SxIP is very clear from the homology.</p><disp-quote content-type="editor-comment"><p>Figure 3B; Figure S2: Hard to recognize the peptide (MACF in green).</p></disp-quote><p>We increased the size of 3D and S2, making it easier to see the peptide.</p><disp-quote content-type="editor-comment"><p>Figure 1C and D: Make the residual numbers of the x-axes the same between the two graphs.</p></disp-quote><p>We made new plots with a linear scale for the residue numbers.</p><disp-quote content-type="editor-comment"><p>Figure 2A: The structures shown are not EB1. It should be described as EBH or EB1(191-260 a.a.).</p></disp-quote><p>Corrected.</p><disp-quote content-type="editor-comment"><p>Page 5, line 17: &quot;the S2 values of the C-terminus&quot; should be &quot;the S2 values of the C-terminal loop in EBH&quot;, otherwise it is confusing.</p></disp-quote><p>Corrected.</p><disp-quote content-type="editor-comment"><p>Page 6, line 27; Figure S3C and S6: Please indicate the assignments of the resonances from &quot;253FVI255&quot; in the Figures.</p></disp-quote><p>We labelled the peaks corresponding to the 253FVI255 region in figure S6 (new S7). Figure S3 shows EBH-ΔC that does not include this region.</p><disp-quote content-type="editor-comment"><p>Page 7, line 25: Figure S7 should be S8.</p></disp-quote><p>Corrected</p><disp-quote content-type="editor-comment"><p>Page 12, line 6: &quot;sulfatrahsferases&quot; must by a typo.</p></disp-quote><p>Corrected.</p></body></sub-article></article>